US20050273002A1 - Multi-mode imaging marker - Google Patents

Multi-mode imaging marker Download PDF

Info

Publication number
US20050273002A1
US20050273002A1 US10/709,899 US70989904A US2005273002A1 US 20050273002 A1 US20050273002 A1 US 20050273002A1 US 70989904 A US70989904 A US 70989904A US 2005273002 A1 US2005273002 A1 US 2005273002A1
Authority
US
United States
Prior art keywords
imaging
bioabsorbable
marker
imaging marker
primary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/709,899
Inventor
Ryan Goosen
Steven Field
Richard Chesbrough
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bard Peripheral Vascular Inc
Bard Shannon Ltd USA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US10/709,899 priority Critical patent/US20050273002A1/en
Priority to EP19166774.0A priority patent/EP3524203A3/en
Priority to EP05011761.3A priority patent/EP1602341B1/en
Priority to CA2508982A priority patent/CA2508982C/en
Publication of US20050273002A1 publication Critical patent/US20050273002A1/en
Priority to US11/275,919 priority patent/US8634899B2/en
Assigned to BARD SHANNON LIMITED, BARD PERIPHERAL VASCULAR, INC. reassignment BARD SHANNON LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: INRAD, INC.
Assigned to INRAD, INC. reassignment INRAD, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GOOSEN, RYAN L., FIELD, STEVEN E., CHESBROUGH, RICHARD M.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743Type of operation; Specification of treatment sites
    • A61B2017/00796Breast surgery
    • A61B2017/008Removal of tumors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3904Markers, e.g. radio-opaque or breast lesions markers specially adapted for marking specified tissue
    • A61B2090/3908Soft tissue, e.g. breast tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3925Markers, e.g. radio-opaque or breast lesions markers ultrasonic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3987Applicators for implanting markers

Definitions

  • the invention relates generally to a device for percutaneously implanting an imaging marker for identifying a location within a tissue mass. More particularly, the invention relates to a device for implanting a subcutaneous imaging marker that comprises at least two elements, each of which have a primary imaging mode.
  • Subcutaneous imaging markers are commonly implanted to identify a particular location in various areas and organs of the body. For example, markers are positioned at biopsy sites so that a practitioner can readily identify the tissue sample location after the biopsy procedure is completed. Markers are also used to denote the locations of lesions for therapeutic procedures, such as chemotherapy.
  • the marker can be viewed using several well-known medical imaging techniques, such as radiography, ultrasonography, and magnetic resonance imaging (MRI).
  • radiography x-rays, which are wavelike forms of electromagnetic energy carried by particles called photons, passed through the body are either scattered, absorbed, or transmitted by the hard and soft tissues. Hard tissues are more likely to absorb the x-ray photons, while the soft tissues tend to transmit the x-ray photons.
  • the transmitted photons are recorded by a detector, such as an x-ray photographic film or a digital receiver, which produces a two-dimensional negative film image. Consequently, bones and other hard tissues appear white in the image, and organs, muscles, and other soft tissues appear black or gray.
  • Mammography is a form of radiography where low dose x-ray photos are passed through a breast under compression to diagnose breast disease in women.
  • CAT computerized axial tomography
  • the x-ray source and the x-ray detectors revolve around the body, or the source remains stationary, and the x-ray beam is bounced off a revolving reflector.
  • a machine records x-ray slices across the body in a spiral motion. After the patient passes through the machine, the computer combines all the information from each scan to form a three-dimensional detailed image of the body.
  • Ultrasonography involves emitting a beam of high frequency, about 3-10 MHz, pulses of acoustic energy from a transmitter and onto body tissue surfaces oriented perpendicular to the transmitter. Some of the acoustic energy pulses reflect at boundaries between tissues having a difference in acoustic impedance, which is a medium's resistance to transmission of acoustic energy, and the echo is detected by an acoustic transducer, which transforms the echo into an electrical pulse. Some of the energy transmits past the boundary until it reaches another boundary where it can reflect back to the transducer.
  • the electric pulse is sent to a computer with a display, and the computer forms a two-dimensional image by determining the proper location of a dot, and its corresponding shade of gray, on the display screen.
  • the computer forms a two-dimensional image by determining the proper location of a dot, and its corresponding shade of gray, on the display screen.
  • body tissue has an acoustical impedance over 3000 times that of air; consequently, entrapped air can be used in subcutaneous imaging markers in order to enhance the visibility of the marker during ultrasonography. Additionally, the texture of the marker can increase the scattering of the acoustical energy pulses.
  • the patient In MRI, the patient is positioned inside a strong magnetic field usually generated by a large bore superconducting magnet. Specifically, the body part to be scanned is placed in the exact center or isocenter of the magnetic field, and the MRI scanner takes several slices that can be combined to form two-dimensional images or three-dimensional models. Markers comprising non-magnetic materials are viewable with MRI.
  • markers have several imaging modes where they can be viewed with any of the above imaging techniques; however, each marker has a primary imaging mode wherein the marker is best viewed or most easily distinguished.
  • a metal clip having a simple, thin shape can be difficult to discern with ultrasonography if the marker is oriented on its side relative to the acoustic emitter.
  • the marker On the display, which is typically grainy, the marker will appear as a very thin, undistinguishable line.
  • such a marker is readily seen with x-ray, regardless of its orientation, because of the sharp contrast in x-ray transmission between the metal and the surrounding soft tissue.
  • the metal marker has an ultrasound imaging mode and an x-ray imaging mode, and the x-ray imaging mode is the primary imaging mode.
  • Other markers such as those with entrapped air, can be seen easily with ultrasonography but are not as visible in an x-ray imaging mode because they transmit the x-ray photons in a manner similar to the soft tissue.
  • Such markers also have an ultrasound imaging mode and an x-ray imaging mode, but the primary imaging mode is the ultrasound imaging mode.
  • a practitioner is most likely to choose a marker that has a primary imaging mode corresponding to a preferred imaging technique. However, such a selection can preclude the effective use of other imaging techniques. For example, in some procedures the marker is permanent and will be imaged multiple times by different technicians over a relatively long time span, possibly over several years. During that time, different imaging techniques might be used. Thus, it is desirable for a marker to have multiple primary modes.
  • an imaging marker for the subcutaneous marking of tissue comprises a first non-bioabsorbable element having a first primary imaging mode and a second non-bioabsorbable element having a second primary imaging mode.
  • the second primary imaging mode is different than the first primary imaging mode.
  • the first primary imaging mode is one of ultrasound, x-ray, CAT, and MRI
  • the second primary imaging mode is one of ultrasound, x-ray, CAT, and MRI.
  • One of the first and second primary imaging modes can be ultrasound and the other of the first and second primary imaging modes can be x-ray.
  • the first non-bioabsorbable element is expandable in volume and made from PVA.
  • the second non-bioabsorbable element is made of metal. At least a portion of one of the first and second non-bioabsorbable elements is embedded in the other of the first and second non-bioabsorbable elements. One of the first and second non-bioabsorbable elements can be completely embedded in the other of the first and second non-bioabsorbable elements.
  • the first non-bioabsorbable element comprises a loop that surrounds the second non-bioabsorbable element.
  • the first non-bioabsorbable element comprises a body with a foot, and the foot can form an anchor.
  • the body can be embedded within the second non-bioabsorbable element, and the foot can be embedded within the second non-bioabsorbable element.
  • an imaging marker according to the invention for the subcutaneous marking of tissue comprises a metal element and a PVA element, wherein the metal element and PVA element form a composite body.
  • At least a portion of one of the metal and the PVA elements is embedded in the other of the metal and the PVA elements, and one of the metal and the PVA elements can be completely embedded in the other of the metal and the PVA elements.
  • the metal element comprises a head with an anchor.
  • the head can be embedded within the PVA element.
  • the metal element can comprise a loop from which extends at least one foot, with the loop surrounding the PVA element to form the head and the at least one foot forming the anchor.
  • the loop has an inner diameter and the PVA element has an outer diameter, wherein the PVA element can expand so that the outer diameter is greater than the inner diameter to effect embedding of the one of the metal and the PVA elements in the other of the metal and the PVA elements.
  • the inner diameter can be between 0.010 and 0.030 inches, and the outer diameter can be expanded to approximately twice the inner diameter.
  • the PVA element can be folded against the at least one foot so that the composite body is sized to be received within a hollow needle having a gage of less than 20.
  • the PVA element can be compressed to be sized for receipt within the hollow needle.
  • a marking device for percutaneously implanting an imaging marker comprises a cannula defining a lumen and having a distal end and an expulsion opening near the distal end; a stylet slidably received within the lumen for movement between a ready position in which a tip of the stylet is spaced inwardly from the distal end to form a marker recess therebetween, and an extended position in which the tip of the stylet is advanced toward the distal end; and an imaging marker comprising a first non-bioabsorbable element having a first primary imaging mode, and a second non-bioabsorbable element having a second primary imaging mode, wherein the second primary imaging mode is different than the first primary imaging mode. Movement of the stylet from the ready position to the extended position thereby ejects the imaging marker from the marker recess through the expulsion opening.
  • the marking device further comprises a handle to be grasped by a user, and the cannula has a proximal end mounted to the handle. Further, the marking device comprises an actuator for moving the stylet relative to the cannula.
  • the actuator is mounted to the handle and is a plunger movable between a first position and a second position for moving the stylet between the ready position and the extended position.
  • the cannula, the stylet, the actuator, and the handle form an introducer
  • the introducer and the imaging marker form a self-contained marking device that can be easily and conveniently handled by a user to place the imaging marker at a predetermined location in a tissue mass by the user moving the plunger between the first and second positions to move the stylet from the ready to the extended position to thereby eject the imaging marker from the marker recess after the cannula is inserted into the tissue mass and the insertion tip is located at the predetermined location.
  • the first primary imaging mode is one of ultrasound, x-ray, CAT, and MRI
  • the second primary imaging mode is one of ultrasound, x-ray, CAT, and MRI.
  • One of the first and second primary imaging modes is ultrasound
  • the other of the first and second primary imaging modes is x-ray.
  • the first non-bioabsorbable element is expandable in volume.
  • the first non-bioabsorbable element is made from PVA, and the second non-bioabsorbable element is made of metal.
  • At least a portion of one of the first and second non-bioabsorbable elements is embedded in the other of the first and second non-bioabsorbable elements.
  • the one of the first and second non-bioabsorbable elements can be completely embedded in the other of the first and second non-bioabsorbable elements.
  • the first non-bioabsorbable element comprises a loop that surrounds the second non-bioabsorbable element.
  • the first non-bioabsorbable element comprises a head with at least one foot.
  • the body can be embedded within the second non-bioabsorbable element, and the at least one foot can be embedded within the second non-bioabsorbable element.
  • the at least one foot can form an anchor.
  • FIG. 1 is a plan view of an introducer used to place an imaging marker at a predetermined location in accordance with the invention
  • FIG. 2 is an enlarged sectional view of the area 11 of FIG. 1 , illustrating a first embodiment of an imaging marker according to the invention comprising a clip and a cylinder, wherein the cylinder is in a folded and compressed condition, within a marker recess portion of the introducer prior to ejection;
  • FIG. 3 is a plan view of the introducer of FIG. 1 , wherein the introducer has ejected the imaging marker into a tissue mass;
  • FIG. 4 is an enlarged perspective view of the imaging marker of FIG. 2 , illustrating the cylinder of the imaging marker in a straight configuration
  • FIG. 5 is an enlarged partial sectional view of the imaging marker of FIG. 2 partially ejected from the introducer into a biopsy site;
  • FIG. 6 is an enlarged plan view of the imaging marker of FIG. 2 completely disposed within a biopsy site and wherein the cylinder is in an unfolded and expanded condition;
  • FIG. 7 is an enlarged perspective view of a second embodiment of an imaging marker according to the invention.
  • FIG. 8 is an enlarged perspective view of a third embodiment of an imaging marker according to the invention.
  • FIG. 9 is an enlarged perspective view of a fourth embodiment of an imaging marker according to the invention.
  • FIG. 10 is an enlarged perspective view of a fifth embodiment of an imaging marker according to the invention.
  • the invention addresses the deficiencies of the prior art and provides a marking device for percutaneously implanting an imaging marker comprising at least two elements, wherein each element has a primary imaging mode different from the primary imaging modes of the other elements.
  • FIGS. 1 to 3 illustrate a marking device 10 according to the invention, which is capable of the percutaneous placement of an imaging marker at a predetermined location, such as a biopsy site or a lesion, within a tissue mass 100 .
  • the marking device 10 comprises an introducer 12 and an imaging marker 14 ( FIG. 2 ) contained within the introducer 12 .
  • the introducer 12 includes a handle 16 having a hollow interior 18 and a rear opening 20 .
  • the handle 16 comprises a grip portion 22 from which extends a tapered nose portion 24 .
  • the tapered nose portion 24 houses a press-fit cannula 30 , which defines a lumen 32 .
  • the cannula 30 comprises a proximal end 33 mounted to the handle 16 and a distal end 34 having an expulsion opening 36 spaced from the handle 16 .
  • the cannula 30 has a gage of less than 20, and a 17-gage (0.058 inch outer diameter) cannula, with an inner diameter ranging from 0.049 to 0.051 inches, is most preferred.
  • the distal end 34 of the cannula 30 can be sharpened to facilitate insertion through the tissue mass 100 .
  • the distal end 34 of the cannula 30 can be designed for enhanced visibility using common imaging techniques, such as radiography, ultrasonography, and magnetic resonance imaging (MRI).
  • MRI magnetic resonance imaging
  • Suitable cannula tips are disclosed in U.S. Pat. No. 5,490,521, issued Feb. 13, 1996 to R. E. Davis and G. L. McLellan, which is incorporated by reference.
  • Ultrasound enhancement technology is also disclosed in U.S. Pat. No. 4,401,124, issued Aug. 30, 1983 to J. F. Guess et al.; and U.S. Pat. No. 4,582,061, issued Apr. 15, 1986 to F. J. Fry.
  • a stylet 40 comprising a base 44 and shaft 42 with a tip 46 is slidably received within the hollow interior 18 of the handle 16 in a manner such that the shaft 42 extends into the cannula lumen 32 and the stylet base 44 lies within the hollow interior 18 .
  • An actuator in the form of a plunger 50 in operable communication with the stylet base 44 comprises a cylindrical body sized so that it is slidably received within the rear opening 20 of the handle 16 . Linear displacement of the plunger 50 within the rear opening 20 correspondingly shifts the stylet 40 relative to the handle 16 and the cannula 40 .
  • the stylet 40 is movable between a ready position, as best seen in FIG. 2 , and an extended position, as illustrated in FIG. 3 .
  • the tip 46 of the stylet 40 is spaced inwardly from the distal end 34 of the cannula 30 to form a marker recess 48 sized to receive the imaging marker 14 .
  • the tip 46 advances towards the distal end 34 to reduce the volume of the marker recess 48 and thereby eject the marker 14 from the marker recess 48 .
  • the stylet shaft 42 be sized in a manner such that when the plunger 50 is in the extended position, the stylet shaft 42 extends beyond the distal end 34 of the cannula 30 to ensure complete ejection of the imaging marker 14 from the marker recess 48 . Movement of the plunger 50 , which operably engages the stylet base 44 , from a first position ( FIG. 1 ) and towards the handle 16 to a second position ( FIG. 3 ) shifts the stylet 40 from the ready position to the extended position.
  • a first embodiment of the imaging marker 14 comprises a first element 60 and a second element 62 that form a composite body.
  • the first element 60 has several imaging modes. That is, the first element can be imaged by different imaging techniques. Each imaging mode corresponds to a different imaging technique, including, but not limited to, radiography, such as standard x-ray, mammography, and computerized axial tomography (CAT), ultrasonography, and MRI. However, not all imaging modes have the same efficacy.
  • the first element 60 is not necessarily easily viewable in each of the imaging modes and could even be substantially indistinguishable from the surrounding tissue in one or more of the imaging modes.
  • the first element 60 is most readily viewed and easily discernable with a particular imaging technique when located in the tissue mass 100 .
  • the first element 60 can have imaging modes wherein it is viewable with, for example, x-ray, MRI, and ultrasound. If the first element 60 is especially viewable with ultrasound, then, of all the imaging modes, the primary imaging mode for the first element 60 is an ultrasound imaging mode.
  • the second element 62 has several imaging modes and, in at least one of the imaging modes, which is the primary imaging mode, the second element 62 is most readily viewed and easily discernable with a particular imaging technique when located in the tissue mass 100 .
  • the second element 62 can have imaging modes wherein it is viewable with, for example, x-ray, MRI, and ultrasound. If the second element 62 is especially viewable with x-ray, then, of all the imaging modes, the primary imaging mode for the second element 62 is an x-ray imaging mode. However, the primary imaging mode of the second element 62 is different than the primary imaging mode of the first element 60 .
  • the imaging marker 14 has at least two different primary imaging modes and, therefore, can be readily viewed and distinguished from the surrounding tissue with at least two different imaging techniques. For example, if the first and second elements 60 and 62 have primary imaging modes corresponding to ultrasound and x-ray, respectively, then the subcutaneous imaging marker 14 can be identified with both ultrasound and x-ray imaging techniques.
  • the imaging marker 14 can optionally comprise other elements in addition to the first and second elements 60 and 62 , wherein each of the other elements has its own primary imaging mode.
  • the imaging marker can comprise a third element having a third primary imaging mode, a fourth element having a fourth primary imaging mode, and so on.
  • the primary imaging mode of each of the other elements can be unique, can be the same as each other, and can be the same as the first or second primary imaging modes.
  • the imaging marker comprises three elements, wherein the first primary imaging mode is ultrasound and the second primary imaging mode is x-ray
  • the third primary imaging mode can be ultrasound, x-ray, or another imaging mode, such as MRI.
  • Each element of the imaging marker 14 is considered to be a fundamental constituent thereof.
  • An element that is modified to enhance an imaging mode other than its primary imaging mode is considered to constitute more than one element. For example, if a first element having a first primary imaging mode is coated so that it is readily viewed and easily discernable with an imaging technique other than that corresponding to the first imaging mode, then the coating is considered to be a second element with a second primary imaging mode.
  • Other examples of modifying elements include adding texture to a surface of an element; immersing an element in a material for impregnation thereof; and blowing air into an element to form pockets or pores of air. In these examples, the texture, the material, and the air are considered to be fundamental constituents of the imaging marker and separate elements having their own primary imaging modes.
  • the first element 60 is composed of a biocompatible, non-bioabsorbable, and flexible material, preferably polyvinyl alcohol (PVA). Additionally, the first element has a compressible and expandable form, for example, a sponge-like element comprising several small pores (not shown) that undergoes a volumetric change during compression or expansion. When the first element 60 is outside the body, the pores are filled with gas, such as air. In this state, the sponge-like form is easily compressed such that the overall volume of the first element 60 reduces. Conversely, when the first element 60 is introduced into the tissue mass 100 , water and other liquids from the tissue enter the pores and thereby swell or expand the first element 60 to a larger volume.
  • PVA polyvinyl alcohol
  • the preferred primary imaging mode of the first element 60 is an ultrasound imaging mode.
  • the second element 62 is composed of a biocompatible, non-bioabsorbable, and substantially rigid material, preferably a metal, including, but not limited to, titanium and stainless steel. Metals have a significantly lower x-ray transmission relative to soft tissue and, therefore, are clearly distinguishable from surrounding tissue with radiographic imaging techniques, regardless of the orientation of the second element 62 . Consequently, the preferred primary imaging mode of the second element 62 is a radiographic imaging mode, such as an x-ray imaging mode. It follows that the imaging marker 14 implanted into the tissue mass 100 can be clearly and consistently viewed with both ultrasonography and radiography, such as x-ray.
  • the imaging marker 14 can optionally be modified to incorporate another element.
  • the first element 60 can be soaked in a material, such as iodine or gadolinium, that is viewable with an imaging technique.
  • Iodine and gadolinium are exemplary materials that are known to be viewable with MRI.
  • the material impregnates the first element 60 and renders the imaging marker 14 viewable with MRI. Consequently, the imaging marker 14 with the first element 60 impregnated with the material comprises a third element, which is the material, having a third primary imaging mode, which is MRI.
  • the first element 60 is in the shape of an elongated cylinder 64 with an outer diameter
  • the second element 62 is a clip 66 with a head 68 and a pair of feet 70 .
  • the head 68 and feet 70 are separated by a region 72 where the clip 62 crosses over itself.
  • the head 68 forms a loop, with an inner diameter, that receives the cylinder 64
  • the feet 70 function as anchors to secure the imaging marker 14 within the tissue mass 10 and prevent migration after implantation.
  • the cylinder 64 can be flexed from a straight configuration, as illustrated in FIG. 4 , to a folded condition, as shown in FIG. 2 , so that the imaging marker 14 is sized to be received within the lumen 32 of the cannula 30 .
  • the cylinder 64 In the folded condition, the cylinder 64 is bent near its center into somewhat of a U-shape.
  • the cylinder is folded substantially in half against the cross region 72 and the feet 70 of the clip 66 .
  • the ends of the cylinder 64 preferably extend beyond the feet 70 .
  • the feet 70 of the clip 66 can be squeezed together slightly, if necessary, to fit the imaging marker 14 within the lumen 32 .
  • the outer diameter of the cylinder 64 can significantly alter during compression or expansion.
  • the first element 64 can be compressed, if necessary, to reduce the outer diameter so that it is less than inner diameter of the head 68 .
  • the first element 64 can be compressed to fit the imaging marker 14 within the marker recess 48 .
  • the outer diameter increases, preferably to a dimension greater than the inner diameter of the head 68 . Because the cylinder 64 , in the expanded condition, is larger than the head 68 , the head 68 effectively pinches the cylinder 64 near its center, as best viewed in FIG. 6 , and the two elements 60 and 62 exert opposing forces upon each other and become embedded. As a result of the embedding, the two elements 60 and 62 form a bond that prevents separation of the cylinder 64 from the clip 66 .
  • first and second elements 60 and 62 for the first embodiment of the imaging marker 14 will now be presented. These dimensions are for illustrative purposes and are not meant to limit the invention in any manner. It is well within the scope of the invention for the dimensions of the first and second elements 60 and 62 to differ from those provided hereinafter provided that the imaging marker is sized to be received within the cannula 30 , regardless of the size thereof. As stated above, the cannula 30 is preferably less than 20 gage, and a 17-gage cannula with a 0.049 to 0.051 inch inner diameter is preferred. The cannula 30 , however, is not limited to this size, and, thus, the dimensions of the imaging marker 14 shall not be limited in a similar manner.
  • the cylinder 64 has a length and outer diameter of 0.315 and 0.040 inches, respectively.
  • the height of the clip 66 is preferably 0.120 inches, and the width of the clip 66 at the feet 70 is 0.055 inches and at the head 68 is 0.045 inches.
  • the inner diameter of the head 68 is preferably 0.021 inches. It is apparent that, for the imaging marker 14 with the above dimensions, the cylinder 64 of must be compressed for insertion through the head 68 and that expansion of the cylinder 64 to its original size or larger will cause embedding of the first and second elements 60 and 62 .
  • the above exemplary dimensions are preferred and are suitable for an imaging marker that can be uses in a hand-held marking device with a 20-gage or less cannula.
  • Such hand-held devices are relatively small and less invasive when compared to other systems, such as the Mammotome® Breast Biopsy System.
  • the introducer 12 begins with the stylet 40 in the ready position ( FIG. 2 ) and the plunger 50 in the first position ( FIG. 1 ). With the introducer 12 in this condition, the cannula 30 is positioned so that its distal end 34 is at or near the predetermined location, which is illustrated as a biopsy site 102 in FIGS. 3, 5 , and 6 , in the tissue mass 100 . Preferably, the distal end 34 of the cannula 30 is positioned by using a suitable imaging system.
  • the plunger 50 is moved from its first position to the second position to displace the stylet 40 from the ready position to the extended position, as shown in FIG. 3 .
  • the plunger 50 drives the stylet base 44 forward to advance the stylet shaft 42 within the lumen 32 .
  • the tip 46 pushes the imaging marker 14 through the marker recess 48 such that the imaging marker 14 extends from the distal end 34 of the cannula, as illustrated in FIG. 5 .
  • the imaging marker 14 is completely ejected from the marker recess 48 and is disposed at the predetermined location within the tissue mass 100 .
  • the tissue mass 100 can resist the advancement of the imaging marker 14 .
  • PVA in a sponge-like form is relatively weak, thus making it difficult for first element 60 to push through the tissue mass on its own.
  • the second element 62 is composed of metal, it dominates the resistive forces from the tissue mass 100 and delivers the first element 60 to the predetermined location.
  • the cross region 72 of the clip 66 pulls the cylinder 64 , which is in the folded condition, along with the clip 66 to the predetermined location.
  • the cylinder 64 upon ejection, unfolds and expands as it absorbs liquid from the tissue mass 100 .
  • the degree to which the cylinder 64 unfolds is governed by the geometry and structure of the predetermined location. If the predetermined location is a biopsy site 102 having a dimension larger than the length of the cylinder 64 , then typically the cylinder 64 will unfold until it becomes constrained by the cavity walls of the biopsy site 102 . Upon expansion, the cylinder 64 and the head 68 become embedded, thereby securing the first and second elements 60 and 62 together. Additionally, the feet 70 anchor the imaging marker 14 to the predetermined location to prevent migration of the imaging marker 14 within the tissue mass 100 .
  • the subcutaneous imaging marker 14 is easily viewed in either of the primary imaging modes of the first and second elements 60 and 62 .
  • a practitioner can identify the imaging marker 14 and, therefore, pinpoint the predetermined location using either ultrasound, which is the primary imaging mode of the first element 60 , or x-ray, which is the primary imaging mode of the second element 62 .
  • ultrasound which is the primary imaging mode of the first element 60
  • x-ray which is the primary imaging mode of the second element 62 .
  • the practitioner has the luxury of being able to select the imaging technique most suitable for the patient.
  • FIGS. 7-10 Alternative embodiments of the imaging marker 14 according to the invention are illustrated in FIGS. 7-10 where similar components are identified with the same reference numeral bearing a prime (′) symbol.
  • the alternative embodiments are substantially the same as the first embodiment, with the primary difference being the form of the second element 62 and the manner in which it is coupled to the first element 60 .
  • an imaging marker 14 ′ comprise a first element 60 ′ and a second element 62 ′.
  • the second element 62 ′ is preferably a clip 66 ′ with a head 68 ′ and a pair of feet 70 ′ separated by a cross region 72 ′.
  • the first element 60 ′ comprises various forms, as depicted in FIGS. 7-10 . Regardless of the form of the first element 60 ′, at least a portion of each of the first and second elements 60 ′ and 62 ′ are embedded to secure the elements 60 ′ and 62 ′ together to form a composite body.
  • the first element 60 ′ is in the form of two cylinders 64 ′ mounted onto the feet 70 ′ of the clip 66 ′.
  • an adhesive such as an ultraviolet (UV) curable adhesive, facilitates the mounting the cylinders 64 ′.
  • UV curable adhesive is a cyanoacrylate adhesive.
  • the head 68 ′ of the second embodiment functions as an anchor to prevent migration of the imaging marker 14 ′.
  • the first element 60 ′ of third and fourth embodiments which are illustrated in FIGS. 8 and 9 , is in the form of a block 80 .
  • the head 68 ′ of the clip 66 ′ is embedded within the block 80
  • the entire clip 66 ′ is embedded in the block 80 in the fourth embodiment.
  • the clip 66 ′ is also completely embedded within the first element 60 ′, but the first element 60 ′ is in the form of a cylinder 64 ′.
  • FIGS. 7-10 are ejected from the marker recess 48 of the marking device 10 and into the predetermined location within the tissue mass 100 in the same manner as the first embodiment.
  • the imaging markers 14 ′ can be clearly viewed and distinguished from the surrounding tissue with imaging techniques corresponding to the primary imaging modes of the first and second elements 60 ′ and 62 ′.
  • the imaging marker is described above as comprising two non-bioabsorbable elements, each with a different primary imaging mode, the invention shall not be limited to comprising only two non-bioabsorbable elements. It is within the scope of the invention for the imaging marker to comprise more than two non-bioabsorbable elements, each with a different primary imaging mode. Further, each non-bioabsorbable element can have more than one primary imaging mode provided that one of the primary imaging modes is different from the primary imaging mode(s) of the other element(s). For example, if the second element is comprised of a non-magnetic metal, such as titanium, and can be viewed with MRI as well as with x-ray, then the second element could have two primary imaging modes.
  • a non-magnetic metal such as titanium
  • the first element is the form of a cylinder or block, and the second element is shown as a clip; however, the first and second elements can be of any suitable shape that can be received within the cannula and implanted into a tissue mass.
  • the imaging marker is not limited to use with the marking device detailed above. The imaging marker can be implanted with a device that is not self-contained or with a self-contained marking device other than that described herein.
  • the imaging marker according to the invention can be easily viewed and readily distinguished from the surrounding tissue with more than one medical imaging technique. Because a practitioner is not limited to locating the imaging marker with only one technique, he or she has the flexibility of being able to select the imaging technique most suitable, both physically and financially, for the patient. Furthermore, the non-bioabsorbable imaging marker is securely embedded together and anchored to the predetermined location to provide a reliable and enduring marker for the predetermined location.

Abstract

The invention provides a device for percutaneously implanting an imaging marker for identifying a location within a tissue mass. The subcutaneous imaging marker comprises at least a first element and a second element, each of which have a primary imaging mode. The primary imaging mode of the first element is different from that of the second element.

Description

    FIELD OF THE INVENTION
  • The invention relates generally to a device for percutaneously implanting an imaging marker for identifying a location within a tissue mass. More particularly, the invention relates to a device for implanting a subcutaneous imaging marker that comprises at least two elements, each of which have a primary imaging mode.
  • DESCRIPTION OF THE RELATED ART
  • Subcutaneous imaging markers are commonly implanted to identify a particular location in various areas and organs of the body. For example, markers are positioned at biopsy sites so that a practitioner can readily identify the tissue sample location after the biopsy procedure is completed. Markers are also used to denote the locations of lesions for therapeutic procedures, such as chemotherapy.
  • Once the marker is implanted, it can be viewed using several well-known medical imaging techniques, such as radiography, ultrasonography, and magnetic resonance imaging (MRI). In radiography, x-rays, which are wavelike forms of electromagnetic energy carried by particles called photons, passed through the body are either scattered, absorbed, or transmitted by the hard and soft tissues. Hard tissues are more likely to absorb the x-ray photons, while the soft tissues tend to transmit the x-ray photons. The transmitted photons are recorded by a detector, such as an x-ray photographic film or a digital receiver, which produces a two-dimensional negative film image. Consequently, bones and other hard tissues appear white in the image, and organs, muscles, and other soft tissues appear black or gray. Mammography is a form of radiography where low dose x-ray photos are passed through a breast under compression to diagnose breast disease in women. In computerized axial tomography (CAT), another form of radiography, the x-ray source and the x-ray detectors revolve around the body, or the source remains stationary, and the x-ray beam is bounced off a revolving reflector. A machine records x-ray slices across the body in a spiral motion. After the patient passes through the machine, the computer combines all the information from each scan to form a three-dimensional detailed image of the body.
  • Ultrasonography involves emitting a beam of high frequency, about 3-10 MHz, pulses of acoustic energy from a transmitter and onto body tissue surfaces oriented perpendicular to the transmitter. Some of the acoustic energy pulses reflect at boundaries between tissues having a difference in acoustic impedance, which is a medium's resistance to transmission of acoustic energy, and the echo is detected by an acoustic transducer, which transforms the echo into an electrical pulse. Some of the energy transmits past the boundary until it reaches another boundary where it can reflect back to the transducer. The electric pulse is sent to a computer with a display, and the computer forms a two-dimensional image by determining the proper location of a dot, and its corresponding shade of gray, on the display screen. As the difference in acoustic impedance at a boundary increases, more sound energy is reflected. Body tissue has an acoustical impedance over 3000 times that of air; consequently, entrapped air can be used in subcutaneous imaging markers in order to enhance the visibility of the marker during ultrasonography. Additionally, the texture of the marker can increase the scattering of the acoustical energy pulses.
  • In MRI, the patient is positioned inside a strong magnetic field usually generated by a large bore superconducting magnet. Specifically, the body part to be scanned is placed in the exact center or isocenter of the magnetic field, and the MRI scanner takes several slices that can be combined to form two-dimensional images or three-dimensional models. Markers comprising non-magnetic materials are viewable with MRI.
  • Generally speaking, markers have several imaging modes where they can be viewed with any of the above imaging techniques; however, each marker has a primary imaging mode wherein the marker is best viewed or most easily distinguished. For example, a metal clip having a simple, thin shape can be difficult to discern with ultrasonography if the marker is oriented on its side relative to the acoustic emitter. On the display, which is typically grainy, the marker will appear as a very thin, undistinguishable line. On the other hand, such a marker is readily seen with x-ray, regardless of its orientation, because of the sharp contrast in x-ray transmission between the metal and the surrounding soft tissue. Accordingly, the metal marker has an ultrasound imaging mode and an x-ray imaging mode, and the x-ray imaging mode is the primary imaging mode. Other markers, such as those with entrapped air, can be seen easily with ultrasonography but are not as visible in an x-ray imaging mode because they transmit the x-ray photons in a manner similar to the soft tissue. Such markers also have an ultrasound imaging mode and an x-ray imaging mode, but the primary imaging mode is the ultrasound imaging mode. In selecting a marker, a practitioner is most likely to choose a marker that has a primary imaging mode corresponding to a preferred imaging technique. However, such a selection can preclude the effective use of other imaging techniques. For example, in some procedures the marker is permanent and will be imaged multiple times by different technicians over a relatively long time span, possibly over several years. During that time, different imaging techniques might be used. Thus, it is desirable for a marker to have multiple primary modes.
  • SUMMARY OF THE INVENTION
  • According to the invention, an imaging marker for the subcutaneous marking of tissue comprises a first non-bioabsorbable element having a first primary imaging mode and a second non-bioabsorbable element having a second primary imaging mode. The second primary imaging mode is different than the first primary imaging mode.
  • The first primary imaging mode is one of ultrasound, x-ray, CAT, and MRI, and the second primary imaging mode is one of ultrasound, x-ray, CAT, and MRI. One of the first and second primary imaging modes can be ultrasound and the other of the first and second primary imaging modes can be x-ray.
  • The first non-bioabsorbable element is expandable in volume and made from PVA. The second non-bioabsorbable element is made of metal. At least a portion of one of the first and second non-bioabsorbable elements is embedded in the other of the first and second non-bioabsorbable elements. One of the first and second non-bioabsorbable elements can be completely embedded in the other of the first and second non-bioabsorbable elements.
  • The first non-bioabsorbable element comprises a loop that surrounds the second non-bioabsorbable element.
  • The first non-bioabsorbable element comprises a body with a foot, and the foot can form an anchor. The body can be embedded within the second non-bioabsorbable element, and the foot can be embedded within the second non-bioabsorbable element.
  • In another aspect, an imaging marker according to the invention for the subcutaneous marking of tissue comprises a metal element and a PVA element, wherein the metal element and PVA element form a composite body.
  • At least a portion of one of the metal and the PVA elements is embedded in the other of the metal and the PVA elements, and one of the metal and the PVA elements can be completely embedded in the other of the metal and the PVA elements.
  • The metal element comprises a head with an anchor. The head can be embedded within the PVA element. The metal element can comprise a loop from which extends at least one foot, with the loop surrounding the PVA element to form the head and the at least one foot forming the anchor. The loop has an inner diameter and the PVA element has an outer diameter, wherein the PVA element can expand so that the outer diameter is greater than the inner diameter to effect embedding of the one of the metal and the PVA elements in the other of the metal and the PVA elements. The inner diameter can be between 0.010 and 0.030 inches, and the outer diameter can be expanded to approximately twice the inner diameter. The PVA element can be folded against the at least one foot so that the composite body is sized to be received within a hollow needle having a gage of less than 20. The PVA element can be compressed to be sized for receipt within the hollow needle.
  • According to the invention, a marking device for percutaneously implanting an imaging marker comprises a cannula defining a lumen and having a distal end and an expulsion opening near the distal end; a stylet slidably received within the lumen for movement between a ready position in which a tip of the stylet is spaced inwardly from the distal end to form a marker recess therebetween, and an extended position in which the tip of the stylet is advanced toward the distal end; and an imaging marker comprising a first non-bioabsorbable element having a first primary imaging mode, and a second non-bioabsorbable element having a second primary imaging mode, wherein the second primary imaging mode is different than the first primary imaging mode. Movement of the stylet from the ready position to the extended position thereby ejects the imaging marker from the marker recess through the expulsion opening.
  • The marking device further comprises a handle to be grasped by a user, and the cannula has a proximal end mounted to the handle. Further, the marking device comprises an actuator for moving the stylet relative to the cannula. The actuator is mounted to the handle and is a plunger movable between a first position and a second position for moving the stylet between the ready position and the extended position.
  • The cannula, the stylet, the actuator, and the handle form an introducer, and the introducer and the imaging marker form a self-contained marking device that can be easily and conveniently handled by a user to place the imaging marker at a predetermined location in a tissue mass by the user moving the plunger between the first and second positions to move the stylet from the ready to the extended position to thereby eject the imaging marker from the marker recess after the cannula is inserted into the tissue mass and the insertion tip is located at the predetermined location.
  • The first primary imaging mode is one of ultrasound, x-ray, CAT, and MRI, and the second primary imaging mode is one of ultrasound, x-ray, CAT, and MRI. One of the first and second primary imaging modes is ultrasound, and the other of the first and second primary imaging modes is x-ray.
  • The first non-bioabsorbable element is expandable in volume. The first non-bioabsorbable element is made from PVA, and the second non-bioabsorbable element is made of metal.
  • At least a portion of one of the first and second non-bioabsorbable elements is embedded in the other of the first and second non-bioabsorbable elements. The one of the first and second non-bioabsorbable elements can be completely embedded in the other of the first and second non-bioabsorbable elements.
  • The first non-bioabsorbable element comprises a loop that surrounds the second non-bioabsorbable element.
  • The first non-bioabsorbable element comprises a head with at least one foot. The body can be embedded within the second non-bioabsorbable element, and the at least one foot can be embedded within the second non-bioabsorbable element. The at least one foot can form an anchor.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • In the drawings:
  • FIG. 1 is a plan view of an introducer used to place an imaging marker at a predetermined location in accordance with the invention;
  • FIG. 2 is an enlarged sectional view of the area 11 of FIG. 1, illustrating a first embodiment of an imaging marker according to the invention comprising a clip and a cylinder, wherein the cylinder is in a folded and compressed condition, within a marker recess portion of the introducer prior to ejection;
  • FIG. 3 is a plan view of the introducer of FIG. 1, wherein the introducer has ejected the imaging marker into a tissue mass;
  • FIG. 4 is an enlarged perspective view of the imaging marker of FIG. 2, illustrating the cylinder of the imaging marker in a straight configuration;
  • FIG. 5 is an enlarged partial sectional view of the imaging marker of FIG. 2 partially ejected from the introducer into a biopsy site;
  • FIG. 6 is an enlarged plan view of the imaging marker of FIG. 2 completely disposed within a biopsy site and wherein the cylinder is in an unfolded and expanded condition;
  • FIG. 7 is an enlarged perspective view of a second embodiment of an imaging marker according to the invention;
  • FIG. 8 is an enlarged perspective view of a third embodiment of an imaging marker according to the invention;
  • FIG. 9 is an enlarged perspective view of a fourth embodiment of an imaging marker according to the invention; and
  • FIG. 10 is an enlarged perspective view of a fifth embodiment of an imaging marker according to the invention.
  • DESCRIPTION OF THE INVENTION
  • The invention addresses the deficiencies of the prior art and provides a marking device for percutaneously implanting an imaging marker comprising at least two elements, wherein each element has a primary imaging mode different from the primary imaging modes of the other elements.
  • Referring now to the figures, FIGS. 1 to 3 illustrate a marking device 10 according to the invention, which is capable of the percutaneous placement of an imaging marker at a predetermined location, such as a biopsy site or a lesion, within a tissue mass 100. The marking device 10 comprises an introducer 12 and an imaging marker 14 (FIG. 2) contained within the introducer 12. The introducer 12 includes a handle 16 having a hollow interior 18 and a rear opening 20. The handle 16 comprises a grip portion 22 from which extends a tapered nose portion 24.
  • The tapered nose portion 24 houses a press-fit cannula 30, which defines a lumen 32. The cannula 30 comprises a proximal end 33 mounted to the handle 16 and a distal end 34 having an expulsion opening 36 spaced from the handle 16. Preferably, the cannula 30 has a gage of less than 20, and a 17-gage (0.058 inch outer diameter) cannula, with an inner diameter ranging from 0.049 to 0.051 inches, is most preferred. Optionally, the distal end 34 of the cannula 30 can be sharpened to facilitate insertion through the tissue mass 100. Furthermore, the distal end 34 of the cannula 30 can be designed for enhanced visibility using common imaging techniques, such as radiography, ultrasonography, and magnetic resonance imaging (MRI). Suitable cannula tips are disclosed in U.S. Pat. No. 5,490,521, issued Feb. 13, 1996 to R. E. Davis and G. L. McLellan, which is incorporated by reference. Ultrasound enhancement technology is also disclosed in U.S. Pat. No. 4,401,124, issued Aug. 30, 1983 to J. F. Guess et al.; and U.S. Pat. No. 4,582,061, issued Apr. 15, 1986 to F. J. Fry.
  • A stylet 40 comprising a base 44 and shaft 42 with a tip 46 is slidably received within the hollow interior 18 of the handle 16 in a manner such that the shaft 42 extends into the cannula lumen 32 and the stylet base 44 lies within the hollow interior 18. An actuator in the form of a plunger 50 in operable communication with the stylet base 44 comprises a cylindrical body sized so that it is slidably received within the rear opening 20 of the handle 16. Linear displacement of the plunger 50 within the rear opening 20 correspondingly shifts the stylet 40 relative to the handle 16 and the cannula 40.
  • The stylet 40 is movable between a ready position, as best seen in FIG. 2, and an extended position, as illustrated in FIG. 3. In the ready position, the tip 46 of the stylet 40 is spaced inwardly from the distal end 34 of the cannula 30 to form a marker recess 48 sized to receive the imaging marker 14. When the stylet 40 moves to the extended position, the tip 46 advances towards the distal end 34 to reduce the volume of the marker recess 48 and thereby eject the marker 14 from the marker recess 48. It is preferred that the stylet shaft 42 be sized in a manner such that when the plunger 50 is in the extended position, the stylet shaft 42 extends beyond the distal end 34 of the cannula 30 to ensure complete ejection of the imaging marker 14 from the marker recess 48. Movement of the plunger 50, which operably engages the stylet base 44, from a first position (FIG. 1) and towards the handle 16 to a second position (FIG. 3) shifts the stylet 40 from the ready position to the extended position.
  • Further details of the introducer 12 are provided in U.S. Pat. No. 6,575,991, issued Jun. 10, 2003 to R. M Chesbrough et al., which is incorporated herein by reference.
  • It will be recognized that the foregoing construction provides a self-contained marking device, which may be preassembled as a unit and prepackaged, all under sterile conditions, thereby affording the practitioner substantially greater convenience and reliability.
  • Referring now to FIG. 4, a first embodiment of the imaging marker 14 according to the invention comprises a first element 60 and a second element 62 that form a composite body. The first element 60 has several imaging modes. That is, the first element can be imaged by different imaging techniques. Each imaging mode corresponds to a different imaging technique, including, but not limited to, radiography, such as standard x-ray, mammography, and computerized axial tomography (CAT), ultrasonography, and MRI. However, not all imaging modes have the same efficacy. The first element 60 is not necessarily easily viewable in each of the imaging modes and could even be substantially indistinguishable from the surrounding tissue in one or more of the imaging modes. Conversely, in at least one of the imaging modes, which will be referred to as a primary imaging mode, the first element 60 is most readily viewed and easily discernable with a particular imaging technique when located in the tissue mass 100. For example, the first element 60 can have imaging modes wherein it is viewable with, for example, x-ray, MRI, and ultrasound. If the first element 60 is especially viewable with ultrasound, then, of all the imaging modes, the primary imaging mode for the first element 60 is an ultrasound imaging mode.
  • Similar to the first element 60, the second element 62 has several imaging modes and, in at least one of the imaging modes, which is the primary imaging mode, the second element 62 is most readily viewed and easily discernable with a particular imaging technique when located in the tissue mass 100. For example, the second element 62 can have imaging modes wherein it is viewable with, for example, x-ray, MRI, and ultrasound. If the second element 62 is especially viewable with x-ray, then, of all the imaging modes, the primary imaging mode for the second element 62 is an x-ray imaging mode. However, the primary imaging mode of the second element 62 is different than the primary imaging mode of the first element 60. Because the first and second elements 60 and 62 have different primary imaging modes, the imaging marker 14 has at least two different primary imaging modes and, therefore, can be readily viewed and distinguished from the surrounding tissue with at least two different imaging techniques. For example, if the first and second elements 60 and 62 have primary imaging modes corresponding to ultrasound and x-ray, respectively, then the subcutaneous imaging marker 14 can be identified with both ultrasound and x-ray imaging techniques.
  • The imaging marker 14 can optionally comprise other elements in addition to the first and second elements 60 and 62, wherein each of the other elements has its own primary imaging mode. For example, the imaging marker can comprise a third element having a third primary imaging mode, a fourth element having a fourth primary imaging mode, and so on. The primary imaging mode of each of the other elements can be unique, can be the same as each other, and can be the same as the first or second primary imaging modes. For example, if the imaging marker comprises three elements, wherein the first primary imaging mode is ultrasound and the second primary imaging mode is x-ray, the third primary imaging mode can be ultrasound, x-ray, or another imaging mode, such as MRI.
  • Each element of the imaging marker 14 is considered to be a fundamental constituent thereof. An element that is modified to enhance an imaging mode other than its primary imaging mode is considered to constitute more than one element. For example, if a first element having a first primary imaging mode is coated so that it is readily viewed and easily discernable with an imaging technique other than that corresponding to the first imaging mode, then the coating is considered to be a second element with a second primary imaging mode. Other examples of modifying elements include adding texture to a surface of an element; immersing an element in a material for impregnation thereof; and blowing air into an element to form pockets or pores of air. In these examples, the texture, the material, and the air are considered to be fundamental constituents of the imaging marker and separate elements having their own primary imaging modes.
  • The first element 60 is composed of a biocompatible, non-bioabsorbable, and flexible material, preferably polyvinyl alcohol (PVA). Additionally, the first element has a compressible and expandable form, for example, a sponge-like element comprising several small pores (not shown) that undergoes a volumetric change during compression or expansion. When the first element 60 is outside the body, the pores are filled with gas, such as air. In this state, the sponge-like form is easily compressed such that the overall volume of the first element 60 reduces. Conversely, when the first element 60 is introduced into the tissue mass 100, water and other liquids from the tissue enter the pores and thereby swell or expand the first element 60 to a larger volume. Not all of the gas leaves the sponge-like form upon expansion and the absorption of liquid. Some air pockets remain and are readily visible with ultrasound. The combination of the texture, structure, and air pockets of the sponge-like form renders the first element 60 most readily viewable with ultrasound when disposed in the tissue mass 100. Correspondingly, the preferred primary imaging mode of the first element 60 is an ultrasound imaging mode.
  • The second element 62 is composed of a biocompatible, non-bioabsorbable, and substantially rigid material, preferably a metal, including, but not limited to, titanium and stainless steel. Metals have a significantly lower x-ray transmission relative to soft tissue and, therefore, are clearly distinguishable from surrounding tissue with radiographic imaging techniques, regardless of the orientation of the second element 62. Consequently, the preferred primary imaging mode of the second element 62 is a radiographic imaging mode, such as an x-ray imaging mode. It follows that the imaging marker 14 implanted into the tissue mass 100 can be clearly and consistently viewed with both ultrasonography and radiography, such as x-ray.
  • The imaging marker 14 can optionally be modified to incorporate another element. For example, the first element 60 can be soaked in a material, such as iodine or gadolinium, that is viewable with an imaging technique. Iodine and gadolinium are exemplary materials that are known to be viewable with MRI. During the soaking process, the material impregnates the first element 60 and renders the imaging marker 14 viewable with MRI. Consequently, the imaging marker 14 with the first element 60 impregnated with the material comprises a third element, which is the material, having a third primary imaging mode, which is MRI.
  • With continued reference to the first embodiment shown in FIG. 4, the first element 60 is in the shape of an elongated cylinder 64 with an outer diameter, and the second element 62 is a clip 66 with a head 68 and a pair of feet 70. The head 68 and feet 70 are separated by a region 72 where the clip 62 crosses over itself. The head 68 forms a loop, with an inner diameter, that receives the cylinder 64, and the feet 70 function as anchors to secure the imaging marker 14 within the tissue mass 10 and prevent migration after implantation.
  • The cylinder 64 can be flexed from a straight configuration, as illustrated in FIG. 4, to a folded condition, as shown in FIG. 2, so that the imaging marker 14 is sized to be received within the lumen 32 of the cannula 30. In the folded condition, the cylinder 64 is bent near its center into somewhat of a U-shape. In particular, the cylinder is folded substantially in half against the cross region 72 and the feet 70 of the clip 66. The ends of the cylinder 64 preferably extend beyond the feet 70. Additionally, the feet 70 of the clip 66 can be squeezed together slightly, if necessary, to fit the imaging marker 14 within the lumen 32.
  • While the inner diameter of the head 68 is substantially fixed, the outer diameter of the cylinder 64 can significantly alter during compression or expansion. To facilitate insertion of the cylinder 64 through the head 68, as illustrated in FIG. 4, the first element 64 can be compressed, if necessary, to reduce the outer diameter so that it is less than inner diameter of the head 68. Furthermore, the first element 64 can be compressed to fit the imaging marker 14 within the marker recess 48.
  • When the cylinder 64 absorbs liquid and expands, the outer diameter increases, preferably to a dimension greater than the inner diameter of the head 68. Because the cylinder 64, in the expanded condition, is larger than the head 68, the head 68 effectively pinches the cylinder 64 near its center, as best viewed in FIG. 6, and the two elements 60 and 62 exert opposing forces upon each other and become embedded. As a result of the embedding, the two elements 60 and 62 form a bond that prevents separation of the cylinder 64 from the clip 66.
  • Exemplary dimensions of the first and second elements 60 and 62 for the first embodiment of the imaging marker 14 will now be presented. These dimensions are for illustrative purposes and are not meant to limit the invention in any manner. It is well within the scope of the invention for the dimensions of the first and second elements 60 and 62 to differ from those provided hereinafter provided that the imaging marker is sized to be received within the cannula 30, regardless of the size thereof. As stated above, the cannula 30 is preferably less than 20 gage, and a 17-gage cannula with a 0.049 to 0.051 inch inner diameter is preferred. The cannula 30, however, is not limited to this size, and, thus, the dimensions of the imaging marker 14 shall not be limited in a similar manner.
  • Preferably, the cylinder 64 has a length and outer diameter of 0.315 and 0.040 inches, respectively. The height of the clip 66 is preferably 0.120 inches, and the width of the clip 66 at the feet 70 is 0.055 inches and at the head 68 is 0.045 inches. Additionally, the inner diameter of the head 68 is preferably 0.021 inches. It is apparent that, for the imaging marker 14 with the above dimensions, the cylinder 64 of must be compressed for insertion through the head 68 and that expansion of the cylinder 64 to its original size or larger will cause embedding of the first and second elements 60 and 62.
  • The above exemplary dimensions are preferred and are suitable for an imaging marker that can be uses in a hand-held marking device with a 20-gage or less cannula. Such hand-held devices are relatively small and less invasive when compared to other systems, such as the Mammotome® Breast Biopsy System. However, it is within the scope of the invention to alter the dimensions of the imaging marker so that it can be used with larger, non-hand-held systems.
  • Referring now to FIGS. 1-3 and FIGS. 5 and 6, in operation, the introducer 12 begins with the stylet 40 in the ready position (FIG. 2) and the plunger 50 in the first position (FIG. 1). With the introducer 12 in this condition, the cannula 30 is positioned so that its distal end 34 is at or near the predetermined location, which is illustrated as a biopsy site 102 in FIGS. 3, 5, and 6, in the tissue mass 100. Preferably, the distal end 34 of the cannula 30 is positioned by using a suitable imaging system.
  • Once the cannula 30 is positioned at the predetermined location, the plunger 50 is moved from its first position to the second position to displace the stylet 40 from the ready position to the extended position, as shown in FIG. 3. As the plunger 50 moves, it drives the stylet base 44 forward to advance the stylet shaft 42 within the lumen 32. As the stylet shaft 42 progresses through the lumen 32, the tip 46 pushes the imaging marker 14 through the marker recess 48 such that the imaging marker 14 extends from the distal end 34 of the cannula, as illustrated in FIG. 5. When the stylet shaft 42 is fully advanced, the imaging marker 14 is completely ejected from the marker recess 48 and is disposed at the predetermined location within the tissue mass 100.
  • During the ejection process, the tissue mass 100 can resist the advancement of the imaging marker 14. PVA in a sponge-like form is relatively weak, thus making it difficult for first element 60 to push through the tissue mass on its own. Because the second element 62 is composed of metal, it dominates the resistive forces from the tissue mass 100 and delivers the first element 60 to the predetermined location. As the imaging marker 14 advances through the marker recess 48 and into the tissue mass 100, the cross region 72 of the clip 66 pulls the cylinder 64, which is in the folded condition, along with the clip 66 to the predetermined location.
  • As depicted in FIG. 6, the cylinder 64, upon ejection, unfolds and expands as it absorbs liquid from the tissue mass 100. The degree to which the cylinder 64 unfolds is governed by the geometry and structure of the predetermined location. If the predetermined location is a biopsy site 102 having a dimension larger than the length of the cylinder 64, then typically the cylinder 64 will unfold until it becomes constrained by the cavity walls of the biopsy site 102. Upon expansion, the cylinder 64 and the head 68 become embedded, thereby securing the first and second elements 60 and 62 together. Additionally, the feet 70 anchor the imaging marker 14 to the predetermined location to prevent migration of the imaging marker 14 within the tissue mass 100.
  • After implantation, the subcutaneous imaging marker 14 is easily viewed in either of the primary imaging modes of the first and second elements 60 and 62. A practitioner can identify the imaging marker 14 and, therefore, pinpoint the predetermined location using either ultrasound, which is the primary imaging mode of the first element 60, or x-ray, which is the primary imaging mode of the second element 62. As a result of the ability to clearly view the imaging marker 14 with multiple imaging techniques, the practitioner has the luxury of being able to select the imaging technique most suitable for the patient.
  • Alternative embodiments of the imaging marker 14 according to the invention are illustrated in FIGS. 7-10 where similar components are identified with the same reference numeral bearing a prime (′) symbol. The alternative embodiments are substantially the same as the first embodiment, with the primary difference being the form of the second element 62 and the manner in which it is coupled to the first element 60.
  • In general, the alternative embodiments of an imaging marker 14′ comprise a first element 60′ and a second element 62′. As in the first embodiment, the second element 62′ is preferably a clip 66′ with a head 68′ and a pair of feet 70′ separated by a cross region 72′. The first element 60′, on the other hand, comprises various forms, as depicted in FIGS. 7-10. Regardless of the form of the first element 60′, at least a portion of each of the first and second elements 60′ and 62′ are embedded to secure the elements 60′ and 62′ together to form a composite body.
  • In a second embodiment of the imaging marker 14′ shown in FIG. 7, the first element 60′ is in the form of two cylinders 64′ mounted onto the feet 70′ of the clip 66′. Preferably, an adhesive, such as an ultraviolet (UV) curable adhesive, facilitates the mounting the cylinders 64′. An example of a UV curable adhesive is a cyanoacrylate adhesive. The head 68′ of the second embodiment functions as an anchor to prevent migration of the imaging marker 14′.
  • The first element 60′ of third and fourth embodiments, which are illustrated in FIGS. 8 and 9, is in the form of a block 80. In the third embodiment, the head 68′ of the clip 66′ is embedded within the block 80, while the entire clip 66′ is embedded in the block 80 in the fourth embodiment. In a fifth embodiment, the clip 66′ is also completely embedded within the first element 60′, but the first element 60′ is in the form of a cylinder 64′.
  • The alternative embodiments in FIGS. 7-10 are ejected from the marker recess 48 of the marking device 10 and into the predetermined location within the tissue mass 100 in the same manner as the first embodiment. After implantation, the imaging markers 14′ can be clearly viewed and distinguished from the surrounding tissue with imaging techniques corresponding to the primary imaging modes of the first and second elements 60′ and 62′.
  • While the imaging marker is described above as comprising two non-bioabsorbable elements, each with a different primary imaging mode, the invention shall not be limited to comprising only two non-bioabsorbable elements. It is within the scope of the invention for the imaging marker to comprise more than two non-bioabsorbable elements, each with a different primary imaging mode. Further, each non-bioabsorbable element can have more than one primary imaging mode provided that one of the primary imaging modes is different from the primary imaging mode(s) of the other element(s). For example, if the second element is comprised of a non-magnetic metal, such as titanium, and can be viewed with MRI as well as with x-ray, then the second element could have two primary imaging modes.
  • In the five embodiments presented herein, the first element is the form of a cylinder or block, and the second element is shown as a clip; however, the first and second elements can be of any suitable shape that can be received within the cannula and implanted into a tissue mass. Additionally, the imaging marker is not limited to use with the marking device detailed above. The imaging marker can be implanted with a device that is not self-contained or with a self-contained marking device other than that described herein.
  • The imaging marker according to the invention can be easily viewed and readily distinguished from the surrounding tissue with more than one medical imaging technique. Because a practitioner is not limited to locating the imaging marker with only one technique, he or she has the flexibility of being able to select the imaging technique most suitable, both physically and financially, for the patient. Furthermore, the non-bioabsorbable imaging marker is securely embedded together and anchored to the predetermined location to provide a reliable and enduring marker for the predetermined location.
  • While the invention has been specifically described in connection with certain specific embodiments thereof, it is to be understood that this is by way of illustration and not of limitation, and the scope of the appended claims should be construed as broadly as the prior art will permit.

Claims (54)

1. An imaging marker for the subcutaneous marking of tissue, comprising:
a first non-bioabsorbable element having a first primary imaging mode; and
a second non-bioabsorbable element having a second primary imaging mode;
wherein the second primary imaging mode is different than the first primary imaging mode.
2. The imaging marker of claim 1 wherein the first primary imaging mode is one of ultrasound, x-ray, CAT, and MRI.
3. The imaging marker of claim 2 wherein the second primary imaging mode is one of ultrasound, x-ray, CAT, and MRI.
4. The imaging marker of claim 3 wherein one of the first and second primary imaging modes is ultrasound and the other of the first and second primary imaging modes is x-ray.
5. The imaging marker of claim 1 wherein the first non-bioabsorbable element is expandable in volume.
6. The imaging marker of claim 5 wherein the first non-bioabsorbable element is made from PVA.
7. The imaging marker of claim 6 wherein the second non-bioabsorbable element is made of metal.
8. The imaging marker of claim 7 wherein at least a portion of one of the first and second non-bioabsorbable elements is embedded in the other of the first and second non-bioabsorbable elements.
9. The imaging marker of claim 8 wherein the first primary imaging mode is ultrasound and the second primary imaging mode is x-ray.
10. The imaging marker of claim 1 wherein the first non-bioabsorbable element is made from PVA.
11. The imaging marker of claim 10 wherein the second non-bioabsorbable element is made of metal.
12. The imaging marker of claim 1 wherein at least a portion of one of the first and second non-bioabsorbable elements is embedded in the other of the first and second non-bioabsorbable elements.
13. The imaging marker of claim 12 wherein the one of the first and second non-bioabsorbable elements is completely embedded in the other of the first and second non-bioabsorbable elements.
14. The imaging marker of claim 12 wherein the first non-bioabsorbable element comprises a loop that surrounds the second non-bioabsorbable element.
15. The imaging marker of claim 12 wherein the first non-bioabsorbable element comprises a body with a foot.
16. The imaging marker of claim 15 wherein the body is embedded within the second non-bioabsorbable element.
17. The imaging marker of claim 15 wherein the foot is embedded within the second non-bioabsorbable element.
18. The imaging marker of claim 15 wherein the foot forms an anchor.
19. The imaging marker of claim 1 and further comprising at least one additional non-bioabsorbable element, wherein each additional element has a primary imaging mode.
20. An imaging marker for the subcutaneous marking of tissue, comprising:
a metal element; and
a PVA element;
wherein the metal element and PVA element form a composite body.
21. The imaging marker of claim 20 wherein at least a portion of one of the metal and the PVA elements is embedded in the other of the metal and the PVA elements.
22. The imaging marker of claim 21 wherein the one of the metal and the PVA elements is completely embedded in the other of the metal and the PVA elements.
23. The imaging marker of claim 21 wherein the metal element comprises a head with an anchor.
24. The imaging marker of claim 23 wherein the head is embedded within the PVA element.
25. The imaging marker of claim 23 wherein the metal element comprises a loop from which extends at least one foot, with the loop surrounding the PVA element to form the head and the at least one foot forming the anchor.
26. The imaging marker of claim 25 wherein the loop has an inner diameter and the PVA element has an outer diameter, wherein the PVA element can expand so that the outer diameter is greater than the inner diameter to effect embedding of the one of the metal and the PVA elements in the other of the metal and the PVA elements.
27. The imaging marker of claim 26 wherein the inner diameter is between 0.010 and 0.030 inches.
28. The imaging marker of claim 27 wherein the outer diameter can be expanded to approximately twice the inner diameter.
29. The imaging marker of claim 25 wherein the PVA element can be folded against the at least one foot so that the composite body is sized to be received within a hollow needle having a gage of less than 20.
30. The imaging marker of claim 29 wherein the PVA element can be compressed to be sized for receipt within the hollow needle.
31. A marking device for percutaneously implanting an imaging marker, comprising:
a cannula defining a lumen and having a distal end and an expulsion opening near the distal end;
a stylet slidably received within the lumen for movement between a ready position in which a tip of the stylet is spaced inwardly from the distal end to form a marker recess therebetween, and an extended position in which the tip of the stylet is advanced toward the distal end; and
an imaging marker comprising a first non-bioabsorbable element having a first primary imaging mode, and a second non-bioabsorbable element having a second primary imaging mode, wherein the second primary imaging mode is different than the first primary imaging mode;
wherein movement of the stylet from the ready position to the extended position thereby ejects the imaging marker from the marker recess through the expulsion opening.
32. The marking device of claim 31 and further comprising a handle to be grasped by a user and the cannula having a proximal end mounted to the handle.
33. The marking device of claim 32 and further comprising an actuator for moving the stylet relative to the cannula.
34. The marking device of claim 33 wherein the actuator is mounted to the handle.
35. The marking device of claim 34 wherein the actuator is a plunger movable between a first position and a second position for moving the stylet between the ready position and the extended position.
36. The marking device of claim 35 wherein the cannula, the stylet, the actuator, and the handle form an introducer, and the introducer and the imaging marker form a self-contained marking device that can be easily and conveniently handled by a user to place the imaging marker at a predetermined location in a tissue mass by the user moving the plunger between the first and second positions to move the stylet from the ready to the extended position to thereby eject the imaging marker from the marker recess after the cannula is inserted into the tissue mass and the insertion tip is located at the predetermined location.
37. The marking device of claim 36 wherein the first primary imaging mode is one of ultrasound, x-ray, CAT, and MRI.
38. The marking device of claim 37 wherein the second primary imaging mode is one of ultrasound, x-ray, CAT, and MRI.
39. The marking device of claim 38 wherein one of the first and second primary imaging modes is ultrasound and the other of the first and second primary imaging modes is x-ray.
40. The marking device of claim 31 wherein the first non-bioabsorbable element is expandable in volume.
41. The marking device of claim 40 wherein the first non-bioabsorbable element is made from PVA.
42. The marking device of claim 41 wherein the second non-bioabsorbable element is made of metal.
43. The marking device of claim 31 wherein at least a portion of one of the first and second non-bioabsorbable elements is embedded in the other of the first and second non-bioabsorbable elements.
44. The marking device of claim 43 wherein the one of the first and second non-bioabsorbable elements is completely embedded in the other of the first and second non-bioabsorbable elements.
45. The marking device of claim 43 wherein the first non-bioabsorbable element comprises a loop that surrounds the second non-bioabsorbable element.
46. The marking device of claim 43 wherein the first non-bioabsorbable element comprises a head with at least one foot.
47. The marking device of claim 46 wherein the body is embedded within the second non-bioabsorbable element.
48. The marking device of claim 46 wherein the at least one foot is embedded within the second non-bioabsorbable element.
49. The marking device of claim 46 wherein the at least one foot forms an anchor.
50. A non-bioabsorbable imaging marker for the subcutaneous marking of tissue, comprising:
a first primary imaging mode and
a second primary imaging mode,
wherein the second primary imaging mode is different than the first primary imaging mode.
51. The non-bioabsorbable imaging marker of claim 50 wherein the first primary imaging mode is one of ultrasound, x-ray, CAT, and MRI.
52. The non-bioabsorbable imaging marker of claim 51 wherein the second primary imaging mode is one of ultrasound, x-ray, CAT, and MRI.
53. The non-bioabsorbable imaging marker of claim 52 wherein one of the first and second primary imaging modes is ultrasound and the other of the first and second primary imaging modes is x-ray.
54. The non-bioabsorbable imaging marker of claim 50 and further comprising at least one additional primary imaging mode.
US10/709,899 2003-11-17 2004-06-04 Multi-mode imaging marker Abandoned US20050273002A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US10/709,899 US20050273002A1 (en) 2004-06-04 2004-06-04 Multi-mode imaging marker
EP19166774.0A EP3524203A3 (en) 2004-06-04 2005-05-31 Multi-mode imaging marker
EP05011761.3A EP1602341B1 (en) 2004-06-04 2005-05-31 Multi-mode imaging marker
CA2508982A CA2508982C (en) 2004-06-04 2005-06-01 Multi-mode imaging marker
US11/275,919 US8634899B2 (en) 2003-11-17 2006-02-03 Multi mode imaging marker

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/709,899 US20050273002A1 (en) 2004-06-04 2004-06-04 Multi-mode imaging marker

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/707,044 Continuation-In-Part US7424320B2 (en) 2002-11-18 2003-11-17 Tissue localizing and marking device and method of using same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/275,919 Continuation US8634899B2 (en) 2003-11-17 2006-02-03 Multi mode imaging marker

Publications (1)

Publication Number Publication Date
US20050273002A1 true US20050273002A1 (en) 2005-12-08

Family

ID=34937107

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/709,899 Abandoned US20050273002A1 (en) 2003-11-17 2004-06-04 Multi-mode imaging marker
US11/275,919 Expired - Lifetime US8634899B2 (en) 2003-11-17 2006-02-03 Multi mode imaging marker

Family Applications After (1)

Application Number Title Priority Date Filing Date
US11/275,919 Expired - Lifetime US8634899B2 (en) 2003-11-17 2006-02-03 Multi mode imaging marker

Country Status (3)

Country Link
US (2) US20050273002A1 (en)
EP (2) EP1602341B1 (en)
CA (1) CA2508982C (en)

Cited By (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060173280A1 (en) * 2003-11-17 2006-08-03 Inrad, Inc. Multi Mode Imaging Marker
DE102006024245A1 (en) * 2006-05-23 2007-08-02 Siemens Ag Medical instrument such as a neural implant, biopsy needle or an artificial landmark for implanting into human body, comprises a sample for permitting localization of the medical instruments into the human body, and transponder
WO2008004952A1 (en) * 2006-07-05 2008-01-10 Forsman, Mats Reference means for precision radiation treatment
US20080234572A1 (en) * 2007-03-23 2008-09-25 Civco Medical Instruments Co., Inc. Fiducial marker with absorbable connecting sleeve and absorbable spacer for imaging localization
US20090216115A1 (en) * 2004-07-23 2009-08-27 Calypso Medical Technologies, Inc. Anchoring wirless markers within a human body
US20090310020A1 (en) * 2006-07-05 2009-12-17 Koninklijke Philips Electronics N.V. Enhanced "ticker" application
US7819820B2 (en) 2003-11-17 2010-10-26 Bard Peripheral Vascular, Inc. Self contained, self piercing, side-expelling marking apparatus
US8052708B2 (en) 1999-06-17 2011-11-08 Bard Peripheral Vascular, Inc. Apparatus for the percutaneous marking of a lesion
US8064987B2 (en) 2006-10-23 2011-11-22 C. R. Bard, Inc. Breast marker
US8157862B2 (en) 1997-10-10 2012-04-17 Senorx, Inc. Tissue marking implant
US8177792B2 (en) 2002-06-17 2012-05-15 Senorx, Inc. Plugged tip delivery tube for marker placement
US8219182B2 (en) 1999-02-02 2012-07-10 Senorx, Inc. Cavity-filling biopsy site markers
US8224424B2 (en) 1999-02-02 2012-07-17 Senorx, Inc. Tissue site markers for in vivo imaging
US8311610B2 (en) 2008-01-31 2012-11-13 C. R. Bard, Inc. Biopsy tissue marker
US8361082B2 (en) 1999-02-02 2013-01-29 Senorx, Inc. Marker delivery device with releasable plug
US8401622B2 (en) 2006-12-18 2013-03-19 C. R. Bard, Inc. Biopsy marker with in situ-generated imaging properties
US8419656B2 (en) 2004-11-22 2013-04-16 Bard Peripheral Vascular, Inc. Post decompression marker introducer system
US8447386B2 (en) 2003-05-23 2013-05-21 Senorx, Inc. Marker or filler forming fluid
US8486028B2 (en) 2005-10-07 2013-07-16 Bard Peripheral Vascular, Inc. Tissue marking apparatus having drug-eluting tissue marker
US8498693B2 (en) 1999-02-02 2013-07-30 Senorx, Inc. Intracorporeal marker and marker delivery device
US8626269B2 (en) 2003-05-23 2014-01-07 Senorx, Inc. Fibrous marker and intracorporeal delivery thereof
US8668737B2 (en) 1997-10-10 2014-03-11 Senorx, Inc. Tissue marking implant
US8670818B2 (en) 2008-12-30 2014-03-11 C. R. Bard, Inc. Marker delivery device for tissue marker placement
US8718745B2 (en) 2000-11-20 2014-05-06 Senorx, Inc. Tissue site markers for in vivo imaging
USD715442S1 (en) 2013-09-24 2014-10-14 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD715942S1 (en) 2013-09-24 2014-10-21 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD716450S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD716451S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
US9149341B2 (en) 1999-02-02 2015-10-06 Senorx, Inc Deployment of polysaccharide markers for treating a site within a patient
US9327061B2 (en) 2008-09-23 2016-05-03 Senorx, Inc. Porous bioabsorbable implant
US9579077B2 (en) 2006-12-12 2017-02-28 C.R. Bard, Inc. Multiple imaging mode tissue marker
US9820824B2 (en) 1999-02-02 2017-11-21 Senorx, Inc. Deployment of polysaccharide markers for treating a site within a patent
US9936892B1 (en) * 2009-05-04 2018-04-10 Cortex Manufacturing Inc. Systems and methods for providing a fiducial marker
US9943704B1 (en) 2009-01-21 2018-04-17 Varian Medical Systems, Inc. Method and system for fiducials contained in removable device for radiation therapy
US10182868B2 (en) 2005-11-17 2019-01-22 Varian Medical Systems, Inc. Apparatus and methods for using an electromagnetic transponder in orthopedic procedures
US10342635B2 (en) 2005-04-20 2019-07-09 Bard Peripheral Vascular, Inc. Marking device with retractable cannula
US20210219956A1 (en) * 2013-01-18 2021-07-22 The Johns Hopkins University Ultrasound-detectable markers, ultrasound system, and methods for monitoring vascular flow and patency

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8280486B2 (en) 2004-10-13 2012-10-02 Suros Surgical Systems, Inc. Site marker visable under multiple modalities
US8060183B2 (en) 2004-10-13 2011-11-15 Suros Surgical Systems, Inc. Site marker visible under multiple modalities
US8442623B2 (en) 2004-10-13 2013-05-14 Suros Surgical Systems, Inc. Site marker visible under multiple modalities
US8433391B2 (en) 2004-10-13 2013-04-30 Suros Surgical Systems, Inc. Site marker
US20080033286A1 (en) * 2006-08-02 2008-02-07 Civco Medical Instruments Co., Inc. Fiducial marker for imaging localization and method of using the same
CN102056544B (en) * 2008-06-13 2017-04-12 皇家飞利浦电子股份有限公司 Multimodal imaging fiducial marker
US20110028831A1 (en) * 2009-07-30 2011-02-03 Kent James P Permanently visible implantable fiduciary tissue marker
US9161814B2 (en) 2013-03-15 2015-10-20 Covidien Lp Microwave energy-delivery device and system
US9119650B2 (en) 2013-03-15 2015-09-01 Covidien Lp Microwave energy-delivery device and system
US9301723B2 (en) 2013-03-15 2016-04-05 Covidien Lp Microwave energy-delivery device and system
US10624697B2 (en) 2014-08-26 2020-04-21 Covidien Lp Microwave ablation system
US10813692B2 (en) 2016-02-29 2020-10-27 Covidien Lp 90-degree interlocking geometry for introducer for facilitating deployment of microwave radiating catheter
DE102017211835A1 (en) * 2017-07-11 2019-01-17 Bip Biomedizinische Instrumente Und Produkte Gmbh Medical, implantable marker and device for implanting the marker
US11446114B2 (en) * 2020-01-21 2022-09-20 Med-Genesis, Llc Biopsy marker with anchoring capabilities
US10842591B1 (en) * 2020-01-21 2020-11-24 Med-Genesis, Llc Biopsy marker with anchoring capabilities
JP2023520160A (en) * 2020-03-17 2023-05-16 デビコー・メディカル・プロダクツ・インコーポレイテッド Biopsy site markers with non-migratory features

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5921933A (en) * 1998-08-17 1999-07-13 Medtronic, Inc. Medical devices with echogenic coatings
US6106473A (en) * 1996-11-06 2000-08-22 Sts Biopolymers, Inc. Echogenic coatings
US6234177B1 (en) * 1999-08-12 2001-05-22 Thomas Barsch Apparatus and method for deploying an expandable biopsy marker
US6356782B1 (en) * 1998-12-24 2002-03-12 Vivant Medical, Inc. Subcutaneous cavity marking device and method
US6371904B1 (en) * 1998-12-24 2002-04-16 Vivant Medical, Inc. Subcutaneous cavity marking device and method
US20020151796A1 (en) * 2001-02-09 2002-10-17 Edouard Koulik Echogenic devices and methods of making and using such devices
US20020177776A1 (en) * 1999-04-28 2002-11-28 Ewen James Crawford Kellar Ultrasound detectable instrument
US20020188196A1 (en) * 1999-02-02 2002-12-12 Burbank Fred H. Cavity-filling biopsy site markers
US20020193815A1 (en) * 1994-09-16 2002-12-19 Foerster Seth A. Methods and devices for defining and marking tissue
US6506156B1 (en) * 2000-01-19 2003-01-14 Vascular Control Systems, Inc Echogenic coating
US20040236212A1 (en) * 2003-05-23 2004-11-25 Senorx, Inc. Fibrous marker and intracorporeal delivery thereof
US20050020916A1 (en) * 2003-06-06 2005-01-27 Macfarlane K. Angela Subcutaneous biopsy cavity marker device
US20050234336A1 (en) * 2004-03-26 2005-10-20 Beckman Andrew T Apparatus and method for marking tissue
US20060173280A1 (en) * 2003-11-17 2006-08-03 Inrad, Inc. Multi Mode Imaging Marker

Family Cites Families (451)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2899362A (en) 1959-08-11 Hemostatic sponges and method of
GB708148A (en) 1950-12-18 1954-04-28 Hoechst Ag Hemostatic preparations and process for the manufacture thereof
DE1029528B (en) 1954-01-30 1958-05-08 Med H C Ernst Pohl Dr Device for marking a drill hole to be made, especially for bone nails and bone screws
US2907327A (en) 1957-02-08 1959-10-06 Pfizer & Co C Pellet implanter
US3516412A (en) 1965-08-16 1970-06-23 Electro Catheter Corp Bipolar electrode having irregularity at inserting end thereof and method of insertion
US3402712A (en) 1966-07-19 1968-09-24 American Home Prod Pellet implanter
US3823212A (en) 1968-11-27 1974-07-09 Freudenberg C Fa Process for the production of collagen fiber fabrics in the form of felt-like membranes or sponge-like layers
CS151338B1 (en) 1971-01-22 1973-10-19
US3921632A (en) 1974-08-16 1975-11-25 Frank M Bardani Implant device
US4005699A (en) 1974-10-09 1977-02-01 Louis Bucalo Methods and apparatus for use in magnetic treatment of the body
US4197846A (en) 1974-10-09 1980-04-15 Louis Bucalo Method for structure for situating in a living body agents for treating the body
US4007732A (en) 1975-09-02 1977-02-15 Robert Carl Kvavle Method for location and removal of soft tissue in human biopsy operations
US4041931A (en) 1976-05-17 1977-08-16 Elliott Donald P Radiopaque anastomosis marker
US4217889A (en) 1976-09-15 1980-08-19 Heyer-Schulte Corporation Flap development device and method of progressively increasing skin area
US4105030A (en) 1977-01-03 1978-08-08 Syntex (U.S.A.) Inc. Implant apparatus
US4103690A (en) 1977-03-21 1978-08-01 Cordis Corporation Self-suturing cardiac pacer lead
US4294241A (en) 1977-06-09 1981-10-13 Teruo Miyata Collagen skin dressing
US4588395A (en) 1978-03-10 1986-05-13 Lemelson Jerome H Catheter and method
US4172449A (en) 1978-05-01 1979-10-30 New Research And Development Laboratories, Inc. Body fluid pressure monitor
US4276885A (en) 1979-05-04 1981-07-07 Rasor Associates, Inc Ultrasonic image enhancement
US4331654A (en) 1980-06-13 1982-05-25 Eli Lilly And Company Magnetically-localizable, biodegradable lipid microspheres
US4390018A (en) 1980-09-15 1983-06-28 Zukowski Henry J Method for preventing loss of spinal fluid after spinal tap
US4442843A (en) 1980-11-17 1984-04-17 Schering, Ag Microbubble precursors and methods for their production and use
US4740208A (en) 1980-11-21 1988-04-26 Cavon Joseph F Cast gel implantable prosthesis
US4470160A (en) 1980-11-21 1984-09-11 Cavon Joseph F Cast gel implantable prosthesis
US4428082A (en) 1980-12-08 1984-01-31 Naficy Sadeque S Breast prosthesis with filling valve
US4298998A (en) 1980-12-08 1981-11-10 Naficy Sadeque S Breast prosthesis with biologically absorbable outer container
US4487209A (en) 1981-03-16 1984-12-11 Creative Research And Manufacturing Inc. Biopsy needle
US4401124A (en) 1981-08-13 1983-08-30 Technicare Corporation Reflection enhancement of a biopsy needle
US4400170A (en) 1981-09-29 1983-08-23 Syntex (U.S.A.) Inc. Implanting device and implant magazine
US4582061A (en) 1981-11-18 1986-04-15 Indianapolis Center For Advanced Research, Inc. Needle with ultrasonically reflective displacement scale
US4582640A (en) 1982-03-08 1986-04-15 Collagen Corporation Injectable cross-linked collagen implant material
US4405314A (en) 1982-04-19 1983-09-20 Cook Incorporated Apparatus and method for catheterization permitting use of a smaller gage needle
US4545367A (en) 1982-07-16 1985-10-08 Cordis Corporation Detachable balloon catheter and method of use
US5542915A (en) 1992-08-12 1996-08-06 Vidamed, Inc. Thermal mapping catheter with ultrasound probe
US4438253A (en) 1982-11-12 1984-03-20 American Cyanamid Company Poly(glycolic acid)/poly(alkylene glycol) block copolymers and method of manufacturing the same
GB2138298B (en) 1983-04-21 1986-11-05 Hundon Forge Ltd Pellet implanter
US4647480A (en) 1983-07-25 1987-03-03 Amchem Products, Inc. Use of additive in aqueous cure of autodeposited coatings
US4655226A (en) 1983-12-16 1987-04-07 Southland Instruments, Inc. Disposable biopsy needle unit
CH661199A5 (en) 1983-12-22 1987-07-15 Sulzer Ag MARKING IMPLANT.
US4549560A (en) 1984-03-19 1985-10-29 Andis Company Hair curling appliance with elastomer material covering heating element
CA1295796C (en) 1984-03-27 1992-02-18 Conrad Whyne Biodegradable matrix and methods for producing same
US4648880A (en) 1984-08-30 1987-03-10 Daniel Brauman Implantable prosthetic devices
US4963150B1 (en) 1984-08-30 1994-10-04 Daniel Brauman Implantable prosthetic device
US4820267A (en) 1985-02-19 1989-04-11 Endocon, Inc. Cartridge injector for pellet medicaments
US4863470A (en) 1985-03-19 1989-09-05 Medical Engineering Corporation Identification marker for a breast prosthesis
US5628781A (en) 1985-06-06 1997-05-13 Thomas Jefferson University Implant materials, methods of treating the surface of implants with microvascular endothelial cells, and the treated implants themselves
US4847049A (en) 1985-12-18 1989-07-11 Vitaphore Corporation Method of forming chelated collagen having bactericidal properties
US4693237A (en) 1986-01-21 1987-09-15 Hoffman Richard B Radiopaque coded ring markers for use in identifying surgical grafts
US4682606A (en) 1986-02-03 1987-07-28 Decaprio Vincent H Localizing biopsy apparatus
US4661103A (en) 1986-03-03 1987-04-28 Engineering Development Associates, Ltd. Multiple implant injector
US4832686A (en) 1986-06-24 1989-05-23 Anderson Mark E Method for administering interleukin-2
US4832680A (en) 1986-07-03 1989-05-23 C.R. Bard, Inc. Apparatus for hypodermically implanting a genitourinary prosthesis
EP0402955B1 (en) 1986-07-30 1994-03-09 Sumitomo Pharmaceuticals Company, Limited Solid preparation administering instrument
US4813062A (en) 1986-08-13 1989-03-14 Milliken Research Corporation Radio-opaque marker and method
US4762128A (en) 1986-12-09 1988-08-09 Advanced Surgical Intervention, Inc. Method and apparatus for treating hypertrophy of the prostate gland
US4994028A (en) 1987-03-18 1991-02-19 Endocon, Inc. Injector for inplanting multiple pellet medicaments
US4874376A (en) 1987-04-13 1989-10-17 Hawkins Jr Irvin F Needle guide assembly
ES2086291T3 (en) 1987-05-26 1996-07-01 Sumitomo Pharma DEVICE FOR THE ADMINISTRATION OF SOLID PREPARATIONS.
US4989608A (en) 1987-07-02 1991-02-05 Ratner Adam V Device construction and method facilitating magnetic resonance imaging of foreign objects in a body
US5120802A (en) 1987-12-17 1992-06-09 Allied-Signal Inc. Polycarbonate-based block copolymers and devices
US4889707A (en) 1988-01-29 1989-12-26 The Curators Of The University Of Missouri Composition and method for radiation synovectomy of arthritic joints
US4870966A (en) 1988-02-01 1989-10-03 American Cyanamid Company Bioabsorbable surgical device for treating nerve defects
US5425366A (en) 1988-02-05 1995-06-20 Schering Aktiengesellschaft Ultrasonic contrast agents for color Doppler imaging
EP0327490A1 (en) 1988-02-05 1989-08-09 Schering Aktiengesellschaft Ultrasonic imaging agents, process for their preparation and their diagnostic and therapeutical use
US5374261A (en) 1990-07-24 1994-12-20 Yoon; Inbae Multifunctional devices for use in endoscopic surgical procedures and methods-therefor
US4994013A (en) 1988-07-28 1991-02-19 Best Industries, Inc. Pellet for a radioactive seed
US5702716A (en) 1988-10-03 1997-12-30 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US4950665A (en) 1988-10-28 1990-08-21 Oklahoma Medical Research Foundation Phototherapy using methylene blue
US4909250A (en) 1988-11-14 1990-03-20 Smith Joseph R Implant system for animal identification
US5475052A (en) 1988-11-21 1995-12-12 Collagen Corporation Collagen-synthetic polymer matrices prepared using a multiple step reaction
US5162430A (en) 1988-11-21 1992-11-10 Collagen Corporation Collagen-polymer conjugates
US5800541A (en) 1988-11-21 1998-09-01 Collagen Corporation Collagen-synthetic polymer matrices prepared using a multiple step reaction
AU5154390A (en) 1989-02-15 1990-09-05 Microtek Medical, Inc. Biocompatible material and prosthesis
US5141748A (en) 1989-02-17 1992-08-25 Hoffmann-La Roche, Inc. Implant drug delivery device
US5081997A (en) 1989-03-09 1992-01-21 Vance Products Incorporated Echogenic devices, material and method
US5289831A (en) 1989-03-09 1994-03-01 Vance Products Incorporated Surface-treated stent, catheter, cannula, and the like
US5201314A (en) 1989-03-09 1993-04-13 Vance Products Incorporated Echogenic devices, material and method
US5025797A (en) 1989-03-29 1991-06-25 Baran Gregory W Automated biopsy instrument
GB2230191B (en) 1989-04-15 1992-04-22 Robert Graham Urie Lesion location device
DE8905585U1 (en) 1989-05-03 1989-06-29 Bosch-Siemens Hausgeraete Gmbh, 8000 Muenchen, De
US5012818A (en) 1989-05-04 1991-05-07 Joishy Suresh K Two in one bone marrow surgical needle
US5197482A (en) 1989-06-15 1993-03-30 Research Corporation Technologies, Inc. Helical-tipped lesion localization needle device and method of using the same
US5018530A (en) 1989-06-15 1991-05-28 Research Corporation Technologies, Inc. Helical-tipped lesion localization needle device and method of using the same
US5284479A (en) 1989-08-30 1994-02-08 N.V. Nederlandsche Apparatenfabriek Nedap Implanter
US5271961A (en) 1989-11-06 1993-12-21 Alkermes Controlled Therapeutics, Inc. Method for producing protein microspheres
JPH03158171A (en) 1989-11-17 1991-07-08 Masataka Saito Cap integral type disposal injection needle
US5585112A (en) 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5334381A (en) 1989-12-22 1994-08-02 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5197846A (en) 1989-12-22 1993-03-30 Hitachi, Ltd. Six-degree-of-freedom articulated robot mechanism and assembling and working apparatus using same
GB9003821D0 (en) 1990-02-20 1990-04-18 Danbiosyst Uk Diagnostic aid
JPH042372U (en) 1990-04-23 1992-01-09
US5137928A (en) 1990-04-26 1992-08-11 Hoechst Aktiengesellschaft Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents
AU636481B2 (en) 1990-05-18 1993-04-29 Bracco International B.V. Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
US5236410A (en) 1990-08-02 1993-08-17 Ferrotherm International, Inc. Tumor treatment method
ATE139126T1 (en) 1990-09-10 1996-06-15 Synthes Ag MEMBRANE FOR BONE REGENERATION
US5353804A (en) 1990-09-18 1994-10-11 Peb Biopsy Corporation Method and device for percutaneous exisional breast biopsy
US5391183A (en) 1990-09-21 1995-02-21 Datascope Investment Corp Device and method sealing puncture wounds
US5221269A (en) 1990-10-15 1993-06-22 Cook Incorporated Guide for localizing a nonpalpable breast lesion
US6347240B1 (en) 1990-10-19 2002-02-12 St. Louis University System and method for use in displaying images of a body part
US5282781A (en) 1990-10-25 1994-02-01 Omnitron International Inc. Source wire for localized radiation treatment of tumors
US5370901A (en) 1991-02-15 1994-12-06 Bracco International B.V. Compositions for increasing the image contrast in diagnostic investigations of the digestive tract of patients
US5280788A (en) 1991-02-26 1994-01-25 Massachusetts Institute Of Technology Devices and methods for optical diagnosis of tissue
ATE125452T1 (en) 1991-03-06 1995-08-15 Sueddeutsche Feinmechanik CANNULA FOR DEPOSITING AN ELEMENT.
JP3007903B2 (en) * 1991-03-29 2000-02-14 京セラ株式会社 Artificial disc
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US5147631A (en) 1991-04-30 1992-09-15 Du Pont Merck Pharmaceutical Company Porous inorganic ultrasound contrast agents
US5354623A (en) 1991-05-21 1994-10-11 Cook Incorporated Joint, a laminate, and a method of preparing a nickel-titanium alloy member surface for bonding to another layer of metal
US5242759A (en) 1991-05-21 1993-09-07 Cook Incorporated Joint, a laminate, and a method of preparing a nickel-titanium alloy member surface for bonding to another layer of metal
US5147307A (en) 1991-06-17 1992-09-15 Gluck Seymour M Anatomical marker device and method
US5449560A (en) 1991-07-05 1995-09-12 Dow Corning S.A. Composition suitable for glass laminate interlayer and laminate made therefrom
WO1993000933A1 (en) 1991-07-05 1993-01-21 University Of Rochester Ultrasmall non-aggregated porous particles entrapping gas-bubbles
US5195540A (en) 1991-08-12 1993-03-23 Samuel Shiber Lesion marking process
US5199441A (en) 1991-08-20 1993-04-06 Hogle Hugh H Fine needle aspiration biopsy apparatus and method
NL9101489A (en) 1991-09-03 1993-04-01 Texas Instruments Holland INJECTOR FOR IMMEDIATELY IMPLANTING AN OBJECT IN A LIVING BEING.
US5320100A (en) 1991-09-16 1994-06-14 Atrium Medical Corporation Implantable prosthetic device having integral patency diagnostic indicia
US5344640A (en) 1991-10-22 1994-09-06 Mallinckrodt Medical, Inc. Preparation of apatite particles for medical diagnostic imaging
US5358514A (en) 1991-12-18 1994-10-25 Alfred E. Mann Foundation For Scientific Research Implantable microdevice with self-attaching electrodes
GB9200391D0 (en) 1992-01-09 1992-02-26 Nycomed As Improvements in or relating to contrast agents
FR2686499A1 (en) 1992-01-28 1993-07-30 Technomed Int Sa APPARATUS FOR TREATING A TARGET, SUCH AS A DAMAGE WITHIN THE BODY OF A MAMMAL, PARTICULARLY A HUMAN BEING, USING A MARKING ELEMENT IMPLANTED IN OR IN THE VICINITY OF THE TARGET TO CONTROL THERAPY OF THE SAME TARGET.
WO1993016735A1 (en) 1992-02-28 1993-09-02 Order Stanley E Use of aggregated proteins to prolong retention time of a therapeutic agent adjacent a targeted site such as a tumor
US5674468A (en) 1992-03-06 1997-10-07 Nycomed Imaging As Contrast agents comprising gas-containing or gas-generating polymer microparticles or microballoons
ATE202701T1 (en) 1992-03-06 2001-07-15 Lica Pharmaceuticals As TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES OR BACTERIA
IL104963A (en) 1992-03-06 1997-09-30 Nycomed Imaging As Contrast agents comprising methylene diester unit- containing biodegradable polymers
US5358677A (en) 1992-03-17 1994-10-25 United States Surgical Corporation Methods of forming bioabsorbable objects from polyvinyl alcohol
US6350274B1 (en) 1992-05-11 2002-02-26 Regen Biologics, Inc. Soft tissue closure systems
NL9200844A (en) 1992-05-13 1993-12-01 De Wijdeven Gijsbertus G P Van DEVICE AND METHOD FOR INJECTING WITH A SOLID SUBSTANCE.
US5250026A (en) 1992-05-27 1993-10-05 Destron/Idi, Inc. Adjustable precision transponder injector
US5629008A (en) 1992-06-02 1997-05-13 C.R. Bard, Inc. Method and device for long-term delivery of drugs
US5366756A (en) 1992-06-15 1994-11-22 United States Surgical Corporation Method for treating bioabsorbable implant material
US5281197A (en) 1992-07-27 1994-01-25 Symbiosis Corporation Endoscopic hemostatic agent delivery system
US5469847A (en) 1992-09-09 1995-11-28 Izi Corporation Radiographic multi-modality skin markers
US5368030A (en) 1992-09-09 1994-11-29 Izi Corporation Non-invasive multi-modality radiographic surface markers
US5460182A (en) 1992-09-14 1995-10-24 Sextant Medical Corporation Tissue penetrating apparatus and methods
US5320613A (en) 1993-01-06 1994-06-14 Scimed Life Systems, Inc. Medical lumen flushing and guide wire loading device and method
AU6030994A (en) 1993-01-19 1994-08-15 Lee Hang-Fu Apparatus and method for implant prostheses
DK12293D0 (en) 1993-02-02 1993-02-02 Novo Nordisk As HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE
US5799099A (en) 1993-02-12 1998-08-25 George S. Allen Automatic technique for localizing externally attached fiducial markers in volume images of the head
US5551429A (en) 1993-02-12 1996-09-03 Fitzpatrick; J. Michael Method for relating the data of an image space to physical space
US5362478A (en) 1993-03-26 1994-11-08 Vivorx Pharmaceuticals, Inc. Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
DE4306277C2 (en) 1993-03-01 2000-11-02 Leibinger Gmbh Operation marking tool
US5388588A (en) 1993-05-04 1995-02-14 Nabai; Hossein Biopsy wound closure device and method
US5409004A (en) 1993-06-11 1995-04-25 Cook Incorporated Localization device with radiopaque markings
US5886026A (en) 1993-07-19 1999-03-23 Angiotech Pharmaceuticals Inc. Anti-angiogenic compositions and methods of use
US5494030A (en) 1993-08-12 1996-02-27 Trustees Of Dartmouth College Apparatus and methodology for determining oxygen in biological systems
US5431639A (en) 1993-08-12 1995-07-11 Boston Scientific Corporation Treating wounds caused by medical procedures
US5490521A (en) 1993-08-31 1996-02-13 Medtronic, Inc. Ultrasound biopsy needle
US5676698A (en) 1993-09-07 1997-10-14 Datascope Investment Corp. Soft tissue implant
US5394875A (en) 1993-10-21 1995-03-07 Lewis; Judith T. Automatic ultrasonic localization of targets implanted in a portion of the anatomy
US5433204A (en) 1993-11-16 1995-07-18 Camilla Olson Method of assessing placentation
US5728122A (en) 1994-01-18 1998-03-17 Datascope Investment Corp. Guide wire with releaseable barb anchor
US6241734B1 (en) 1998-08-14 2001-06-05 Kyphon, Inc. Systems and methods for placing materials into bone
US5626611A (en) 1994-02-10 1997-05-06 United States Surgical Corporation Composite bioabsorbable materials and surgical articles made therefrom
US5928773A (en) 1994-02-15 1999-07-27 Vitric Corporation Foamed glass articles and methods of making same and methods of controlling the pH of same within specific limits
US5507807A (en) 1994-03-01 1996-04-16 Shippert; Ronald D. Apparatus for the release of a substance within a patient
US5417708A (en) 1994-03-09 1995-05-23 Cook Incorporated Intravascular treatment system and percutaneous release mechanism therefor
US5422730A (en) 1994-03-25 1995-06-06 Barlow; Clyde H. Automated optical detection of tissue perfusion by microspheres
US5451406A (en) 1994-07-14 1995-09-19 Advanced Uroscience, Inc. Tissue injectable composition and method of use
US6159445A (en) 1994-07-20 2000-12-12 Nycomed Imaging As Light imaging contrast agents
US5954670A (en) 1994-10-05 1999-09-21 Baker; Gary H. Mandrel-guided tandem multiple channel biopsy guide device and method of use
US5891558A (en) 1994-11-22 1999-04-06 Tissue Engineering, Inc. Biopolymer foams for use in tissue repair and reconstruction
US5632432A (en) 1994-12-19 1997-05-27 Ethicon Endo-Surgery, Inc. Surgical instrument
US5499989A (en) 1994-12-22 1996-03-19 Labash; Stephen S. Breast biopsy apparatus and method of use
US6540981B2 (en) 1997-12-04 2003-04-01 Amersham Health As Light imaging contrast agents
US5643246A (en) 1995-02-24 1997-07-01 Gel Sciences, Inc. Electromagnetically triggered, responsive gel based drug delivery device
FR2731343B1 (en) 1995-03-08 1997-08-22 De La Joliniere Jean H Bouquet DEVICE FOR LOCATING SUSPECTED BREAST INJURIES AND APPARATUS FOR PLACING SAME
US5795308A (en) 1995-03-09 1998-08-18 Russin; Lincoln D. Apparatus for coaxial breast biopsy
US5762903A (en) 1995-03-10 1998-06-09 Korea Atomic Energy Research Institute Radioactive chitosan complex for radiation therapy
US5817022A (en) 1995-03-28 1998-10-06 Sonometrics Corporation System for displaying a 2-D ultrasound image within a 3-D viewing environment
US6120536A (en) 1995-04-19 2000-09-19 Schneider (Usa) Inc. Medical devices with long term non-thrombogenic coatings
GB2301362B (en) 1995-05-30 1999-01-06 Johnson & Johnson Medical Absorbable implant materials having controlled porosity
US6774278B1 (en) 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
US5609629A (en) 1995-06-07 1997-03-11 Med Institute, Inc. Coated implantable medical device
US5779647A (en) 1995-06-07 1998-07-14 Chau; Sonny Automated biopsy instruments
US5667767A (en) 1995-07-27 1997-09-16 Micro Therapeutics, Inc. Compositions for use in embolizing blood vessels
US5580568A (en) 1995-07-27 1996-12-03 Micro Therapeutics, Inc. Cellulose diacetate compositions for use in embolizing blood vessels
US5817034A (en) 1995-09-08 1998-10-06 United States Surgical Corporation Apparatus and method for removing tissue
US5611352A (en) 1995-09-14 1997-03-18 Kobren; Myles S. Cervical biopsy device
US6162192A (en) 1998-05-01 2000-12-19 Sub Q, Inc. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US6071301A (en) 1998-05-01 2000-06-06 Sub Q., Inc. Device and method for facilitating hemostasis of a biopsy tract
US6183497B1 (en) 1998-05-01 2001-02-06 Sub-Q, Inc. Absorbable sponge with contrasting agent
AU726713B2 (en) 1995-10-13 2000-11-16 Transvascular, Inc. Methods and apparatus for bypassing arterial obstructions and/or performing other transvascular procedures
US5782775A (en) 1995-10-20 1998-07-21 United States Surgical Corporation Apparatus and method for localizing and removing tissue
CA2187975C (en) 1995-10-20 2001-05-01 Lisa W. Heaton Surgical apparatus and method for marking tissue location
US5800445A (en) 1995-10-20 1998-09-01 United States Surgical Corporation Tissue tagging device
US5782764A (en) 1995-11-07 1998-07-21 Iti Medical Technologies, Inc. Fiber composite invasive medical instruments and methods for use in interventional imaging procedures
US5769086A (en) 1995-12-06 1998-06-23 Biopsys Medical, Inc. Control system and method for automated biopsy device
US6203524B1 (en) 1997-02-10 2001-03-20 Emx, Inc. Surgical and pharmaceutical site access guide and methods
US5800389A (en) 1996-02-09 1998-09-01 Emx, Inc. Biopsy device
US5842477A (en) 1996-02-21 1998-12-01 Advanced Tissue Sciences, Inc. Method for repairing cartilage
US5636255A (en) 1996-03-05 1997-06-03 Queen's University At Kingston Method and apparatus for CT image registration
CA2248076A1 (en) 1996-03-11 1997-09-18 Richard D. Leavitt Polymeric delivery of radionuclides and radiopharmaceuticals
US5747060A (en) 1996-03-26 1998-05-05 Euro-Celtique, S.A. Prolonged local anesthesia with colchicine
US5821184A (en) 1996-03-29 1998-10-13 Andrew Ungerleider Foamed glass article for preparing surfaces, use therefor, and method of making same
US5865806A (en) 1996-04-04 1999-02-02 Becton Dickinson And Company One step catheter advancement automatic needle retraction system
US5824042A (en) 1996-04-05 1998-10-20 Medtronic, Inc. Endoluminal prostheses having position indicating markers
US5669882A (en) 1996-04-23 1997-09-23 Pyles; Stephen Curved epidural needle system
US7236816B2 (en) 1996-04-25 2007-06-26 Johns Hopkins University Biopsy and sampling needle antennas for magnetic resonance imaging-guided biopsies
US5846220A (en) 1996-04-30 1998-12-08 Medtronic, Inc. Therapeutic method for treatment of Alzheimer's disease
US6530896B1 (en) 1996-05-13 2003-03-11 James B. Elliott Apparatus and method for introducing an implant
US5690120A (en) 1996-05-24 1997-11-25 Sarcos, Inc. Hybrid catheter guide wire apparatus
US5853366A (en) 1996-07-08 1998-12-29 Kelsey, Inc. Marker element for interstitial treatment and localizing device and method using same
US5820918A (en) 1996-07-11 1998-10-13 Hercules Incorporated Medical devices containing in-situ generated medical compounds
US5702128A (en) 1996-07-18 1997-12-30 Beekley Corporation Radiographic marker system and method of making same
US5830178A (en) 1996-10-11 1998-11-03 Micro Therapeutics, Inc. Methods for embolizing vascular sites with an emboilizing composition comprising dimethylsulfoxide
US5695480A (en) 1996-07-29 1997-12-09 Micro Therapeutics, Inc. Embolizing compositions
US5823198A (en) 1996-07-31 1998-10-20 Micro Therapeutics, Inc. Method and apparatus for intravasculer embolization
US5842999A (en) 1996-07-31 1998-12-01 C.R. Bard, Inc. Automated tissue sampling device
US5902310A (en) 1996-08-12 1999-05-11 Ethicon Endo-Surgery, Inc. Apparatus and method for marking tissue
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US5676146B1 (en) 1996-09-13 2000-04-18 Osteotech Inc Surgical implant containing a resorbable radiopaque marker and method of locating such within a body
US5824081A (en) 1996-09-13 1998-10-20 Lipomatrix Incorporated Hydraulic foam tissue implant
DE69735354T2 (en) 1996-10-28 2006-11-30 Amersham Health As IMPROVEMENTS AT OR RELATED TO DIAGNOSTIC / THERAPEUTIC COMPOUNDS
US5845646A (en) 1996-11-05 1998-12-08 Lemelson; Jerome System and method for treating select tissue in a living being
US6119031A (en) 1996-11-21 2000-09-12 Boston Scientific Corporation Miniature spectrometer
US5897507A (en) 1996-11-25 1999-04-27 Symbiosis Corporation Biopsy forceps instrument having irrigation and aspiration capabilities
US5876340A (en) 1997-04-17 1999-03-02 Irvine Biomedical, Inc. Ablation apparatus with ultrasonic imaging capabilities
US5941439A (en) 1997-05-14 1999-08-24 Mitek Surgical Products, Inc. Applicator and method for deploying a surgical fastener in tissue
US5876457A (en) 1997-05-20 1999-03-02 George J. Picha Spinal implant
WO1998056435A1 (en) 1997-06-13 1998-12-17 Micro Therapeutics, Inc. Contoured syringe and novel luer hub and methods for embolizing blood vessels
GB9712525D0 (en) 1997-06-16 1997-08-20 Nycomed Imaging As Method
US6306154B1 (en) 1997-06-18 2001-10-23 Bhk Holding Hemostatic system for body cavities
DE19731021A1 (en) 1997-07-18 1999-01-21 Meyer Joerg In vivo degradable metallic implant
US6096037A (en) 1997-07-29 2000-08-01 Medtronic, Inc. Tissue sealing electrosurgery device and methods of sealing tissue
US6096065A (en) 1997-09-29 2000-08-01 Boston Scientific Corporation Sheath for tissue spectroscopy
US5980564A (en) 1997-08-01 1999-11-09 Schneider (Usa) Inc. Bioabsorbable implantable endoprosthesis with reservoir
US6340367B1 (en) 1997-08-01 2002-01-22 Boston Scientific Scimed, Inc. Radiopaque markers and methods of using the same
US6174330B1 (en) 1997-08-01 2001-01-16 Schneider (Usa) Inc Bioabsorbable marker having radiopaque constituents
US6090996A (en) 1997-08-04 2000-07-18 Collagen Matrix, Inc. Implant matrix
JP4127960B2 (en) 1997-08-05 2008-07-30 ボストン サイエンティフィック リミテッド Detachable aneurysm neck bridge
US6316522B1 (en) 1997-08-18 2001-11-13 Scimed Life Systems, Inc. Bioresorbable hydrogel compositions for implantable prostheses
US5854382A (en) 1997-08-18 1998-12-29 Meadox Medicals, Inc. Bioresorbable compositions for implantable prostheses
DE20103363U1 (en) 2001-02-26 2001-05-17 Braun Melsungen Ag Protection device for an injection needle
US6117108A (en) 1997-08-20 2000-09-12 Braun Melsungen Ag Spring clip safety IV catheter
US7125397B2 (en) 1997-08-20 2006-10-24 B. Braun Melsungen Ag Protective device for an injection needle
US6616630B1 (en) 1997-08-20 2003-09-09 B. Braun Melsungen A.G. Spring clip safety IV catheter
US6551253B2 (en) 1997-09-12 2003-04-22 Imagyn Medical Technologies Incisional breast biopsy device
US6142955A (en) 1997-09-19 2000-11-07 United States Surgical Corporation Biopsy apparatus and method
US7637948B2 (en) 1997-10-10 2009-12-29 Senorx, Inc. Tissue marking implant
EP1023004A4 (en) 1997-10-10 2003-03-26 John D Corbitt Breast implant
US6638308B2 (en) 1997-10-10 2003-10-28 John D. Corbitt, Jr. Bioabsorbable breast implant
US6309420B1 (en) 1997-10-14 2001-10-30 Parallax Medical, Inc. Enhanced visibility materials for implantation in hard tissue
US6511468B1 (en) 1997-10-17 2003-01-28 Micro Therapeutics, Inc. Device and method for controlling injection of liquid embolic composition
EP1024832A1 (en) 1997-10-24 2000-08-09 Children's Medical Center Corporation METHODS FOR PROMOTING CELL TRANSFECTION $i(IN VIVO)
US6030333A (en) 1997-10-24 2000-02-29 Radiomed Corporation Implantable radiotherapy device
US6015541A (en) 1997-11-03 2000-01-18 Micro Therapeutics, Inc. Radioactive embolizing compositions
US6270464B1 (en) 1998-06-22 2001-08-07 Artemis Medical, Inc. Biopsy localization method and device
US6251418B1 (en) 1997-12-18 2001-06-26 C.R. Bard, Inc. Systems and methods for local delivery of an agent
ATE329648T1 (en) 1997-12-29 2006-07-15 Alza Corp DEVICE FOR IMPLANTING SUBCUTANEOUS IMPLANTS
US6451871B1 (en) 1998-11-25 2002-09-17 Novartis Ag Methods of modifying surface characteristics
EP1047337B1 (en) 1998-01-14 2007-10-10 Leonard Reiffel System to stabilize an irradiated internal target
US6181960B1 (en) 1998-01-15 2001-01-30 University Of Virginia Patent Foundation Biopsy marker device
US6289229B1 (en) 1998-01-20 2001-09-11 Scimed Life Systems, Inc. Readable probe array for in vivo use
US6660010B2 (en) 1998-01-27 2003-12-09 Scimed Life Systems, Inc. Bone anchor placement device with recessed anchor mount
US6053925A (en) 1998-02-27 2000-04-25 Barnhart; William H. Lesion localization device and method
US6312429B1 (en) 1998-09-01 2001-11-06 Senorx, Inc. Electrosurgical lesion location device
US6638234B2 (en) 1998-03-03 2003-10-28 Senorx, Inc. Sentinel node location and biopsy
US6471700B1 (en) 1998-04-08 2002-10-29 Senorx, Inc. Apparatus and method for accessing biopsy site
US6336904B1 (en) 1998-04-07 2002-01-08 Pro Duct Health, Inc. Methods and devices for the localization of lesions in solid tissue
US6161034A (en) 1999-02-02 2000-12-12 Senorx, Inc. Methods and chemical preparations for time-limited marking of biopsy sites
US6347241B2 (en) 1999-02-02 2002-02-12 Senorx, Inc. Ultrasonic and x-ray detectable biopsy site marker and apparatus for applying it
US6447527B1 (en) 1998-04-23 2002-09-10 Ronald J. Thompson Apparatus and methods for the penetration of tissue
US6610026B2 (en) 1998-05-01 2003-08-26 Sub-Q, Inc. Method of hydrating a sponge material for delivery to a body
US20010045575A1 (en) 1998-05-01 2001-11-29 Mark Ashby Device and method for facilitating hemostasis of a biopsy tract
US6363940B1 (en) 1998-05-14 2002-04-02 Calypso Medical Technologies, Inc. System and method for bracketing and removing tissue
US6224630B1 (en) 1998-05-29 2001-05-01 Advanced Bio Surfaces, Inc. Implantable tissue repair device
US6159143A (en) 1998-06-17 2000-12-12 Scimed Life Systems, Inc. Method and device for delivery of therapeutic agents in conjunction with isotope seed placement
US20020058882A1 (en) 1998-06-22 2002-05-16 Artemis Medical, Incorporated Biopsy localization method and device
DE59913189D1 (en) 1998-06-25 2006-05-04 Biotronik Ag Implantable, bioabsorbable vessel wall support, in particular coronary stent
US6261302B1 (en) 1998-06-26 2001-07-17 Ethicon Endo-Surgery, Inc. Applier for implantable surgical marker
US5941890A (en) 1998-06-26 1999-08-24 Ethicon Endo-Surgery, Inc. Implantable surgical marker
US6179860B1 (en) 1998-08-19 2001-01-30 Artemis Medical, Inc. Target tissue localization device and method
ATE348644T1 (en) 1998-08-21 2007-01-15 Providence Health Sys Oregon IMPLANTABLE STENT AND METHOD FOR PRODUCING SAME
US6335029B1 (en) 1998-08-28 2002-01-01 Scimed Life Systems, Inc. Polymeric coatings for controlled delivery of active agents
US6159240A (en) 1998-08-31 2000-12-12 Medtronic, Inc. Rigid annuloplasty device that becomes compliant after implantation
US6936014B2 (en) 2002-10-16 2005-08-30 Rubicor Medical, Inc. Devices and methods for performing procedures on a breast
US6656192B2 (en) 1998-09-25 2003-12-02 United States Surgical Corporatioin Site marker device
US6056700A (en) 1998-10-13 2000-05-02 Emx, Inc. Biopsy marker assembly and method of use
US6354989B1 (en) 1998-10-14 2002-03-12 Terumo Kabushiki Kaisha Radiation source delivery wire and catheter assembly for radiation therapy provided with the same
US6220248B1 (en) 1998-10-21 2001-04-24 Ethicon Endo-Surgery, Inc. Method for implanting a biopsy marker
WO2000023124A1 (en) 1998-10-22 2000-04-27 Edwards Lifesciences Corporation Multi-functional coatings for medical devices
US6951564B2 (en) 1998-10-23 2005-10-04 United States Surgical Corporation Site marker device
AU1126500A (en) 1998-10-23 2000-05-15 Armand F. Cortese Marker for indicating the location of identified tissue
RU2251437C2 (en) 1998-11-06 2005-05-10 Амершем пи-эл-си Radioactive source for brachytherapy, method of making the device (versions), method of treatment by using the device and composition on its base
US6270472B1 (en) 1998-12-29 2001-08-07 University Of Pittsburgh Of The Commonwealth System Of Higher Education Apparatus and a method for automatically introducing implants into soft tissue with adjustable spacing
US7651505B2 (en) 2002-06-17 2010-01-26 Senorx, Inc. Plugged tip delivery for marker placement
US8498693B2 (en) 1999-02-02 2013-07-30 Senorx, Inc. Intracorporeal marker and marker delivery device
US6725083B1 (en) 1999-02-02 2004-04-20 Senorx, Inc. Tissue site markers for in VIVO imaging
US8282573B2 (en) 2003-02-24 2012-10-09 Senorx, Inc. Biopsy device with selectable tissue receiving aperture orientation and site illumination
US20090030309A1 (en) 2007-07-26 2009-01-29 Senorx, Inc. Deployment of polysaccharide markers
JP3720999B2 (en) 1999-02-18 2005-11-30 沖電気工業株式会社 Input protection circuit
US6200258B1 (en) 1999-08-10 2001-03-13 Syntheon, Llc Radioactive therapeutic seed having selective marker configuration
US6482143B1 (en) 1999-02-28 2002-11-19 Syntheon, Llc Raidoactive therapeutic seed having selective marker configuration
US6173715B1 (en) 1999-03-01 2001-01-16 Lucent Medical Systems, Inc. Magnetic anatomical marker and method of use
US6144875A (en) 1999-03-16 2000-11-07 Accuray Incorporated Apparatus and method for compensating for respiratory and patient motion during treatment
US6712836B1 (en) 1999-05-13 2004-03-30 St. Jude Medical Atg, Inc. Apparatus and methods for closing septal defects and occluding blood flow
WO2000074565A1 (en) 1999-06-05 2000-12-14 Wilson-Cook Medical Inc. Indicia for an endoscopic medical device
US6066122A (en) 1999-06-09 2000-05-23 Fisher; John Needle apparatus and method for marking lesions
US6766186B1 (en) 1999-06-16 2004-07-20 C. R. Bard, Inc. Post biospy tissue marker and method of use
US6575991B1 (en) 1999-06-17 2003-06-10 Inrad, Inc. Apparatus for the percutaneous marking of a lesion
WO2001008578A1 (en) * 1999-07-30 2001-02-08 Vivant Medical, Inc. Device and method for safe location and marking of a cavity and sentinel lymph nodes
US6250307B1 (en) 1999-09-17 2001-06-26 Pi Medical, Inc. Snoring treatment
US8239001B2 (en) 2003-10-17 2012-08-07 Medtronic Navigation, Inc. Method and apparatus for surgical navigation
US6450937B1 (en) 1999-12-17 2002-09-17 C. R. Bard, Inc. Needle for implanting brachytherapy seeds
WO2001049338A1 (en) 1999-12-30 2001-07-12 Li Wei Pin Controlled delivery of therapeutic agents by insertable medical devices
EP1114618A3 (en) 2000-01-04 2001-08-22 Ethicon Endo-Surgery, Inc. Surgical instrument for applying beads to tissue
US6575888B2 (en) 2000-01-25 2003-06-10 Biosurface Engineering Technologies, Inc. Bioabsorbable brachytherapy device
WO2001054588A1 (en) 2000-01-26 2001-08-02 Heartport, Inc. Vascular incisor and method
US6358217B1 (en) 2000-01-31 2002-03-19 Hugh Bourassa Automatic and semi-automatic disposable biopsy needle device
US6436030B2 (en) 2000-01-31 2002-08-20 Om P. Rehil Hiatal hernia repair patch and method for using the same
JP5090600B2 (en) 2000-02-18 2012-12-05 トーマス ジェイ. フォガーティー, Improved device for accurately marking tissues
US6564806B1 (en) 2000-02-18 2003-05-20 Thomas J. Fogarty Device for accurately marking tissue
US6241687B1 (en) 2000-02-18 2001-06-05 Ethicon Endo-Surgery, Inc. Method of use for a biopsy instrument with breakable sample segments
US6350244B1 (en) 2000-02-21 2002-02-26 Biopsy Sciences, Llc Bioabsorable markers for use in biopsy procedures
US6770070B1 (en) 2000-03-17 2004-08-03 Rita Medical Systems, Inc. Lung treatment apparatus and method
US6450938B1 (en) 2000-03-21 2002-09-17 Promex, Llc Brachytherapy device
US6356112B1 (en) 2000-03-28 2002-03-12 Translogic Technology, Inc. Exclusive or/nor circuit
US6628982B1 (en) 2000-03-30 2003-09-30 The Regents Of The University Of Michigan Internal marker device for identification of biological substances
EP1272117A2 (en) 2000-03-31 2003-01-08 Rita Medical Systems, Inc. Tissue biopsy and treatment apparatus and method
US6425903B1 (en) 2000-05-09 2002-07-30 James W. Voegele Implantable surgical marker
US6776796B2 (en) 2000-05-12 2004-08-17 Cordis Corportation Antiinflammatory drug and delivery device
US7419678B2 (en) 2000-05-12 2008-09-02 Cordis Corporation Coated medical devices for the prevention and treatment of vascular disease
US6961608B2 (en) * 2000-06-05 2005-11-01 Kabushiki Kaisha Toshiba Interventional MR imaging with detection and display of device position
US6991652B2 (en) 2000-06-13 2006-01-31 Burg Karen J L Tissue engineering composite
US6423252B1 (en) 2000-06-23 2002-07-23 Ethicon, Inc. Methods of making micropatterned foams
US20020077693A1 (en) 2000-12-19 2002-06-20 Barclay Bruce J. Covered, coiled drug delivery stent and method
US6394965B1 (en) 2000-08-15 2002-05-28 Carbon Medical Technologies, Inc. Tissue marking using biocompatible microparticles
AU2001293109A1 (en) 2000-09-25 2002-04-02 Angiotech Pharmaceuticals (Us), Inc. Resorbable anastomosis stents and plugs
US6716444B1 (en) 2000-09-28 2004-04-06 Advanced Cardiovascular Systems, Inc. Barriers for polymer-coated implantable medical devices and methods for making the same
US6746773B2 (en) 2000-09-29 2004-06-08 Ethicon, Inc. Coatings for medical devices
US6863685B2 (en) 2001-03-29 2005-03-08 Cordis Corporation Radiopacity intraluminal medical device
US7261735B2 (en) 2001-05-07 2007-08-28 Cordis Corporation Local drug delivery devices and methods for maintaining the drug coatings thereon
US6730044B2 (en) 2000-10-13 2004-05-04 Ethicon Endo-Surgery, Inc. Firing mechanism for use in a surgical biopsy device
US6712774B2 (en) 2000-10-13 2004-03-30 James W. Voegele Lockout for a surgical biopsy device
US6540694B1 (en) 2000-10-16 2003-04-01 Sanarus Medical, Inc. Device for biopsy tumors
US6447524B1 (en) 2000-10-19 2002-09-10 Ethicon Endo-Surgery, Inc. Fastener for hernia mesh fixation
US6544185B2 (en) * 2000-10-23 2003-04-08 Valentino Montegrande Ultrasound imaging marker and method of use
US6554760B2 (en) 2000-10-25 2003-04-29 Gary A. Lamoureux Pre-loaded needle assembly
JP4583756B2 (en) 2000-10-31 2010-11-17 クック インコーポレイテッド Medical instruments
US6758824B1 (en) 2000-11-06 2004-07-06 Suros Surgical Systems, Inc. Biopsy apparatus
US6746661B2 (en) 2000-11-16 2004-06-08 Microspherix Llc Brachytherapy seed
WO2002041786A2 (en) * 2000-11-20 2002-05-30 Senorx, Inc. Tissue site markers for in vivo imaging
US20020077687A1 (en) 2000-12-14 2002-06-20 Ahn Samuel S. Catheter assembly for treating ischemic tissue
US6478790B2 (en) 2000-12-22 2002-11-12 Frank M. Bardani Implant device and dosage form employable therein
JP4111829B2 (en) 2001-01-11 2008-07-02 リタ メディカル システムズ インコーポレイテッド Bone treatment instrument
US20020095205A1 (en) 2001-01-12 2002-07-18 Edwin Tarun J. Encapsulated radiopaque markers
US6749627B2 (en) 2001-01-18 2004-06-15 Ev3 Peripheral, Inc. Grip for stent delivery system
US6636758B2 (en) 2001-05-01 2003-10-21 Concentric Medical, Inc. Marker wire and process for using it
US6824527B2 (en) 2001-06-07 2004-11-30 Peter Gollobin Protective sheath for winged needles and sheath and needle assembly
US8197535B2 (en) 2001-06-19 2012-06-12 Cordis Corporation Low profile improved radiopacity intraluminal medical device
US6702744B2 (en) 2001-06-20 2004-03-09 Advanced Cardiovascular Systems, Inc. Agents that stimulate therapeutic angiogenesis and techniques and devices that enable their delivery
US7160258B2 (en) 2001-06-26 2007-01-09 Entrack, Inc. Capsule and method for treating or diagnosing the intestinal tract
US6648849B2 (en) 2001-06-27 2003-11-18 Ethicon, Inc. Medicinal implant and device and method for loading and delivering implants containing drugs and cells
WO2003009764A1 (en) 2001-07-26 2003-02-06 Oregon Health Sciences University Vessel closure member and delivery apparatus
EP1411851B1 (en) 2001-08-03 2006-11-02 Tyco Healthcare Group LP Marker for use with a tissue marking apparatus
US6913626B2 (en) 2001-08-14 2005-07-05 Mcghan Jim J. Medical implant having bioabsorbable textured surface
US6605047B2 (en) 2001-09-10 2003-08-12 Vivant Medical, Inc. Biopsy marker delivery system
US7135978B2 (en) 2001-09-14 2006-11-14 Calypso Medical Technologies, Inc. Miniature resonating marker assembly
US7294118B2 (en) 2001-10-24 2007-11-13 Becton, Dickinson And Company Retractable needle assembly
US6939318B2 (en) 2002-05-03 2005-09-06 Boston Scientific Scimed, Inc. Method, tool, and system for deploying an implant into the body
US8088388B2 (en) 2002-02-14 2012-01-03 United Biomedical, Inc. Stabilized synthetic immunogen delivery system
EP1494611A2 (en) 2002-03-11 2005-01-12 John L. Wardle Surgical coils and methods of deploying
US7527610B2 (en) 2002-03-29 2009-05-05 Bioform Medical, Inc. Connection indicator for a medical delivery/extraction system
JP2005521420A (en) 2002-04-03 2005-07-21 エージーワイ セラピューティクス インコーポレイティッド Use of biomolecular targets in the treatment and visualization of brain tumors
US20030191355A1 (en) 2002-04-04 2003-10-09 Ferguson Patrick J. Hollow bioabsorbable elements for positioning material in living tissue
US6818668B2 (en) 2002-04-12 2004-11-16 Biotest Laboratories, Llc 5-alkyl-7-alkylcarbonate-isoflavone ester and related method
US20030199887A1 (en) * 2002-04-23 2003-10-23 David Ferrera Filamentous embolization device and method of use
US6652442B2 (en) 2002-04-23 2003-11-25 Acueity, Inc. Micro-endoscope assembly for intraductal brachytherapy of a mammary duct and method of using same
US7329414B2 (en) 2002-05-03 2008-02-12 Biopsy Sciences, Llc Biodegradable polymer for marking tissue and sealing tracts
US6780179B2 (en) 2002-05-22 2004-08-24 Rubicor Medical, Inc. Methods and systems for in situ tissue marking and orientation stabilization
US6992233B2 (en) 2002-05-31 2006-01-31 Medafor, Inc. Material delivery system
US7166133B2 (en) 2002-06-13 2007-01-23 Kensey Nash Corporation Devices and methods for treating defects in the tissue of a living being
US20040101548A1 (en) 2002-11-26 2004-05-27 Pendharkar Sanyog Manohar Hemostatic wound dressing containing aldehyde-modified polysaccharide
JP4727987B2 (en) 2002-07-12 2011-07-20 クック インコーポレイテッド Coated medical devices
US20040016195A1 (en) 2002-07-24 2004-01-29 Archuleta John Paul Foamed glass article for use as thermal energy control media
AU2003257087B2 (en) 2002-08-01 2009-01-08 James E. Selis Biopsy devices
US8012454B2 (en) 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
WO2004020024A1 (en) 2002-08-30 2004-03-11 Inrad, Inc. Localizing needle with fluid delivery
US7103418B2 (en) 2002-10-02 2006-09-05 Medtronic, Inc. Active fluid delivery catheter
US20040116802A1 (en) 2002-10-05 2004-06-17 Jessop Precision Products, Inc. Medical imaging marker
US8027712B2 (en) 2002-10-11 2011-09-27 Ion Beam Applications S.A. Elongated markers for soft tissue volume identification
US6994712B1 (en) 2002-11-12 2006-02-07 Biopsy Sciences, Llc Bioabsorbable marker having external anchoring means
US20060036158A1 (en) 2003-11-17 2006-02-16 Inrad, Inc. Self-contained, self-piercing, side-expelling marking apparatus
AU2003290918A1 (en) 2002-11-18 2004-06-15 Chesbrough, Richard, M. Tissue localizing and marking device and method of using same
US7008382B2 (en) 2002-11-20 2006-03-07 Scimed Life Systems, Inc. Medical instrument
US8137288B2 (en) 2002-11-20 2012-03-20 Boston Scientific Scimed, Inc. Medical instrument
US7247160B2 (en) 2002-12-30 2007-07-24 Calypso Medical Technologies, Inc. Apparatuses and methods for percutaneously implanting objects in patients
US6889833B2 (en) 2002-12-30 2005-05-10 Calypso Medical Technologies, Inc. Packaged systems for implanting markers in a patient and methods for manufacturing and using such systems
US20040133124A1 (en) 2003-01-06 2004-07-08 Cook Incorporated. Flexible biopsy needle
WO2004075789A2 (en) 2003-02-26 2004-09-10 Cook Incorporated PROTHESIS ADAPTED FOR PLACEDd UNDER EXTERNAL IMAGING
FR2853521B1 (en) 2003-04-10 2005-12-02 Claude Mialhe DEVICE FOR EXPANDING A VESSEL AND INTRODUCING VASCULAR IMPLANT
US8372112B2 (en) 2003-04-11 2013-02-12 St. Jude Medical, Cardiology Division, Inc. Closure devices, related delivery methods, and related methods of use
US7306580B2 (en) 2003-04-16 2007-12-11 Cook Incorporated Medical device with therapeutic agents
US6945973B2 (en) 2003-05-01 2005-09-20 Nuvasive, Inc. Slidable bone plate system
US7877133B2 (en) 2003-05-23 2011-01-25 Senorx, Inc. Marker or filler forming fluid
US20050119562A1 (en) 2003-05-23 2005-06-02 Senorx, Inc. Fibrous marker formed of synthetic polymer strands
US20040265371A1 (en) 2003-06-25 2004-12-30 Looney Dwayne Lee Hemostatic devices and methods of making same
US7537788B2 (en) 2003-07-25 2009-05-26 Rubicor Medical, Inc. Post-biopsy cavity treatment implants and methods
US7744852B2 (en) 2003-07-25 2010-06-29 Rubicor Medical, Llc Methods and systems for marking post biopsy cavity sites
US20050033157A1 (en) 2003-07-25 2005-02-10 Klein Dean A. Multi-modality marking material and method
US20050049634A1 (en) 2003-08-07 2005-03-03 Scimed Life Systems, Inc. Medical closure device
US7790141B2 (en) 2003-08-11 2010-09-07 Pathak Holdings, Llc Radio-opaque compounds, compositions containing same and methods of their synthesis and use
US7001341B2 (en) 2003-08-13 2006-02-21 Scimed Life Systems, Inc. Marking biopsy sites
US20050059887A1 (en) 2003-09-16 2005-03-17 Hassan Mostafavi Localization of a target using in vivo markers
WO2005037338A1 (en) 2003-10-14 2005-04-28 Cook Incorporated Hydrophilic coated medical device
EP1691852A2 (en) 2003-11-10 2006-08-23 Angiotech International AG Medical implants and fibrosis-inducing agents
US20050112151A1 (en) 2003-11-20 2005-05-26 Horng Liou L. Skin adherent hydrogels
US20050158356A1 (en) 2003-11-20 2005-07-21 Angiotech International Ag Implantable sensors and implantable pumps and anti-scarring agents
US20050113659A1 (en) 2003-11-26 2005-05-26 Albert Pothier Device for data input for surgical navigation system
WO2005053560A1 (en) 2003-11-26 2005-06-16 Invivo Germany Gmbh Tissue marker and method and apparatus for deploying the marker
US20050142161A1 (en) 2003-12-30 2005-06-30 Freeman Lynetta J. Collagen matrix for soft tissue augmentation
US7736671B2 (en) 2004-03-02 2010-06-15 Boston Scientific Scimed, Inc. Embolization
US7761138B2 (en) 2004-03-12 2010-07-20 Boston Scientific Scimed, Inc. MRI and X-ray visualization
US7901707B2 (en) 2004-03-15 2011-03-08 Christine Allen Biodegradable biocompatible implant and method of manufacturing same
US7959634B2 (en) 2004-03-29 2011-06-14 Soteira Inc. Orthopedic surgery access devices
US9638770B2 (en) 2004-05-21 2017-05-02 Devicor Medical Products, Inc. MRI biopsy apparatus incorporating an imageable penetrating portion
US8075568B2 (en) 2004-06-11 2011-12-13 Selis James E Biopsy devices and methods
DE102004030391A1 (en) 2004-06-23 2006-01-26 Somatex Medical Technologies Gmbh marker
US20080097199A1 (en) 2004-08-20 2008-04-24 David Mullen Tissue Marking Devices and Systems
US8280486B2 (en) 2004-10-13 2012-10-02 Suros Surgical Systems, Inc. Site marker visable under multiple modalities
US20060079805A1 (en) 2004-10-13 2006-04-13 Miller Michael E Site marker visable under multiple modalities
US20090076484A1 (en) 2004-10-22 2009-03-19 Kaneka Corporation Therapeutic Catheter
US8419656B2 (en) 2004-11-22 2013-04-16 Bard Peripheral Vascular, Inc. Post decompression marker introducer system
WO2006056739A2 (en) 2004-11-23 2006-06-01 Quantum Medical Technology Limited Surgical tag, magnetometer, and associated system
KR20070104574A (en) 2004-12-30 2007-10-26 신벤션 아게 Combination comprising an agent providing a signal, an implant material and a drug
US7577473B2 (en) 2005-02-03 2009-08-18 Bard Peripheral Vascular, Inc. Apparatus for subcutaneous placement of an imaging marker
DE102005012574A1 (en) 2005-03-18 2006-09-21 Bkh - Technotransfer Gmbh Markers for animal and human tissue, in particular soft tissue
US20060217635A1 (en) 2005-03-24 2006-09-28 Mccombs Elizabeth S Biopsy device marker deployment
JP2008537693A (en) 2005-03-31 2008-09-25 サイティック コーポレーション Internal biopsy marking
US20060241385A1 (en) 2005-04-12 2006-10-26 Ethicon Endo-Surgery, Inc. Guided disposable fiducial for breast biopsy localization fixture
US10357328B2 (en) 2005-04-20 2019-07-23 Bard Peripheral Vascular, Inc. and Bard Shannon Limited Marking device with retractable cannula
CN101243332A (en) 2005-06-21 2008-08-13 纳维斯堪Pet系统有限公司 Tissue interventions using nuclear-emission image guidance
US20060292690A1 (en) 2005-06-22 2006-12-28 Cesco Bioengineering Co., Ltd. Method of making cell growth surface
US7736293B2 (en) 2005-07-22 2010-06-15 Biocompatibles Uk Limited Implants for use in brachytherapy and other radiation therapy that resist migration and rotation
US9498647B2 (en) 2005-09-23 2016-11-22 Allen B. Kantrowitz Fiducial marker system for subject movement compensation during medical treatment
ATE509590T1 (en) 2005-09-26 2011-06-15 Bard Peripheral Vascular Inc SYSTEM FOR INSERTING A MARKER AFTER PRESSURE RELIEF
CA2562580C (en) 2005-10-07 2014-04-29 Inrad, Inc. Drug-eluting tissue marker
US20070083132A1 (en) 2005-10-11 2007-04-12 Sharrow James S Medical device coil
US7761137B2 (en) 2005-12-16 2010-07-20 Suros Surgical Systems, Inc. Biopsy site marker deployment device
US8118786B2 (en) 2006-03-29 2012-02-21 Kawasumi Laboratories, Inc. Guarded medical winged needle assembly
US20070287933A1 (en) 2006-06-08 2007-12-13 Chris Phan Tissue debulking device and method of using the same
US20090171198A1 (en) 2006-08-04 2009-07-02 Jones Michael L Powdered marker
US7945307B2 (en) 2006-08-04 2011-05-17 Senorx, Inc. Marker delivery system with obturator
US20080065218A1 (en) 2006-09-13 2008-03-13 O'neil Michael J Annulus fibrosus repair devices and techniques
ES2443526T3 (en) 2006-10-23 2014-02-19 C.R. Bard, Inc. Breast marker
WO2008073965A2 (en) 2006-12-12 2008-06-19 C.R. Bard Inc. Multiple imaging mode tissue marker
WO2008076973A2 (en) 2006-12-18 2008-06-26 C.R.Bard Inc. Biopsy marker with in situ-generated imaging properties
US20080177179A1 (en) 2006-12-19 2008-07-24 Cytyc Corporation Target Tissue Locator for Image Guided Radiotherapy
US20090024225A1 (en) 2007-07-16 2009-01-22 Stubbs James B Implant for Targeting Therapeutic Procedure

Patent Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050165305A1 (en) * 1994-09-16 2005-07-28 Foerster Seth A. Methods and devices for defining and marking tissue
US20020193815A1 (en) * 1994-09-16 2002-12-19 Foerster Seth A. Methods and devices for defining and marking tissue
US6106473A (en) * 1996-11-06 2000-08-22 Sts Biopolymers, Inc. Echogenic coatings
US5921933A (en) * 1998-08-17 1999-07-13 Medtronic, Inc. Medical devices with echogenic coatings
US6356782B1 (en) * 1998-12-24 2002-03-12 Vivant Medical, Inc. Subcutaneous cavity marking device and method
US20020035324A1 (en) * 1998-12-24 2002-03-21 Sirimanne D. Laksen Subcutaneous cavity marking device and method
US6371904B1 (en) * 1998-12-24 2002-04-16 Vivant Medical, Inc. Subcutaneous cavity marking device and method
US20020107437A1 (en) * 1998-12-24 2002-08-08 Sirimanne D. Laksen Subcutaneous cavity marking device and method
US20020188196A1 (en) * 1999-02-02 2002-12-12 Burbank Fred H. Cavity-filling biopsy site markers
US20020177776A1 (en) * 1999-04-28 2002-11-28 Ewen James Crawford Kellar Ultrasound detectable instrument
US6234177B1 (en) * 1999-08-12 2001-05-22 Thomas Barsch Apparatus and method for deploying an expandable biopsy marker
US6506156B1 (en) * 2000-01-19 2003-01-14 Vascular Control Systems, Inc Echogenic coating
US20020151796A1 (en) * 2001-02-09 2002-10-17 Edouard Koulik Echogenic devices and methods of making and using such devices
US20040236212A1 (en) * 2003-05-23 2004-11-25 Senorx, Inc. Fibrous marker and intracorporeal delivery thereof
US20050020916A1 (en) * 2003-06-06 2005-01-27 Macfarlane K. Angela Subcutaneous biopsy cavity marker device
US20060173280A1 (en) * 2003-11-17 2006-08-03 Inrad, Inc. Multi Mode Imaging Marker
US20050234336A1 (en) * 2004-03-26 2005-10-20 Beckman Andrew T Apparatus and method for marking tissue

Cited By (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9039763B2 (en) 1997-10-10 2015-05-26 Senorx, Inc. Tissue marking implant
US8668737B2 (en) 1997-10-10 2014-03-11 Senorx, Inc. Tissue marking implant
US8157862B2 (en) 1997-10-10 2012-04-17 Senorx, Inc. Tissue marking implant
US8224424B2 (en) 1999-02-02 2012-07-17 Senorx, Inc. Tissue site markers for in vivo imaging
US10172674B2 (en) 1999-02-02 2019-01-08 Senorx, Inc. Intracorporeal marker and marker delivery device
US9649093B2 (en) 1999-02-02 2017-05-16 Senorx, Inc. Cavity-filling biopsy site markers
US8626270B2 (en) 1999-02-02 2014-01-07 Senorx, Inc. Cavity-filling biopsy site markers
US9237937B2 (en) 1999-02-02 2016-01-19 Senorx, Inc. Cavity-filling biopsy site markers
US9149341B2 (en) 1999-02-02 2015-10-06 Senorx, Inc Deployment of polysaccharide markers for treating a site within a patient
US9044162B2 (en) 1999-02-02 2015-06-02 Senorx, Inc. Marker delivery device with releasable plug
US8361082B2 (en) 1999-02-02 2013-01-29 Senorx, Inc. Marker delivery device with releasable plug
US9861294B2 (en) 1999-02-02 2018-01-09 Senorx, Inc. Marker delivery device with releasable plug
US9820824B2 (en) 1999-02-02 2017-11-21 Senorx, Inc. Deployment of polysaccharide markers for treating a site within a patent
US8965486B2 (en) 1999-02-02 2015-02-24 Senorx, Inc. Cavity filling biopsy site markers
US8219182B2 (en) 1999-02-02 2012-07-10 Senorx, Inc. Cavity-filling biopsy site markers
US8498693B2 (en) 1999-02-02 2013-07-30 Senorx, Inc. Intracorporeal marker and marker delivery device
US10463446B2 (en) 1999-06-17 2019-11-05 Bard Peripheral Vascular, Inc. Apparatus for the percutaneous marking of a lesion
US8052708B2 (en) 1999-06-17 2011-11-08 Bard Peripheral Vascular, Inc. Apparatus for the percutaneous marking of a lesion
US9579159B2 (en) 1999-06-17 2017-02-28 Bard Peripheral Vascular, Inc. Apparatus for the percutaneous marking of a lesion
US8579931B2 (en) 1999-06-17 2013-11-12 Bard Peripheral Vascular, Inc. Apparatus for the percutaneous marking of a lesion
US8718745B2 (en) 2000-11-20 2014-05-06 Senorx, Inc. Tissue site markers for in vivo imaging
US8784433B2 (en) 2002-06-17 2014-07-22 Senorx, Inc. Plugged tip delivery tube for marker placement
US8177792B2 (en) 2002-06-17 2012-05-15 Senorx, Inc. Plugged tip delivery tube for marker placement
US10813716B2 (en) 2002-11-18 2020-10-27 Bard Peripheral Vascular, Inc. Self-contained, self-piercing, side-expelling marking apparatus
US9848956B2 (en) 2002-11-18 2017-12-26 Bard Peripheral Vascular, Inc. Self-contained, self-piercing, side-expelling marking apparatus
US8880154B2 (en) 2003-05-23 2014-11-04 Senorx, Inc. Fibrous marker and intracorporeal delivery thereof
US8626269B2 (en) 2003-05-23 2014-01-07 Senorx, Inc. Fibrous marker and intracorporeal delivery thereof
US8639315B2 (en) 2003-05-23 2014-01-28 Senorx, Inc. Marker or filler forming fluid
US8447386B2 (en) 2003-05-23 2013-05-21 Senorx, Inc. Marker or filler forming fluid
US10045832B2 (en) 2003-05-23 2018-08-14 Senorx, Inc. Marker or filler forming fluid
US9801688B2 (en) 2003-05-23 2017-10-31 Senorx, Inc. Fibrous marker and intracorporeal delivery thereof
US8634899B2 (en) * 2003-11-17 2014-01-21 Bard Peripheral Vascular, Inc. Multi mode imaging marker
US20060173280A1 (en) * 2003-11-17 2006-08-03 Inrad, Inc. Multi Mode Imaging Marker
US7819820B2 (en) 2003-11-17 2010-10-26 Bard Peripheral Vascular, Inc. Self contained, self piercing, side-expelling marking apparatus
US20090216115A1 (en) * 2004-07-23 2009-08-27 Calypso Medical Technologies, Inc. Anchoring wirless markers within a human body
US8419656B2 (en) 2004-11-22 2013-04-16 Bard Peripheral Vascular, Inc. Post decompression marker introducer system
US10357328B2 (en) 2005-04-20 2019-07-23 Bard Peripheral Vascular, Inc. and Bard Shannon Limited Marking device with retractable cannula
US11278370B2 (en) 2005-04-20 2022-03-22 Bard Peripheral Vascular, Inc. Marking device with retractable cannula
US10342635B2 (en) 2005-04-20 2019-07-09 Bard Peripheral Vascular, Inc. Marking device with retractable cannula
US8486028B2 (en) 2005-10-07 2013-07-16 Bard Peripheral Vascular, Inc. Tissue marking apparatus having drug-eluting tissue marker
US10182868B2 (en) 2005-11-17 2019-01-22 Varian Medical Systems, Inc. Apparatus and methods for using an electromagnetic transponder in orthopedic procedures
DE102006024245A1 (en) * 2006-05-23 2007-08-02 Siemens Ag Medical instrument such as a neural implant, biopsy needle or an artificial landmark for implanting into human body, comprises a sample for permitting localization of the medical instruments into the human body, and transponder
US20090312633A1 (en) * 2006-07-05 2009-12-17 Anders Widmark Reference means for precision radiation treatment
US20090310020A1 (en) * 2006-07-05 2009-12-17 Koninklijke Philips Electronics N.V. Enhanced "ticker" application
WO2008004952A1 (en) * 2006-07-05 2008-01-10 Forsman, Mats Reference means for precision radiation treatment
EP2056914A4 (en) * 2006-07-05 2011-10-26 Straalen Ab Reference means for precision radiation treatment
EP2056914A1 (en) * 2006-07-05 2009-05-13 Strålen AB Reference means for precision radiation treatment
US8064987B2 (en) 2006-10-23 2011-11-22 C. R. Bard, Inc. Breast marker
US8437834B2 (en) 2006-10-23 2013-05-07 C. R. Bard, Inc. Breast marker
US9579077B2 (en) 2006-12-12 2017-02-28 C.R. Bard, Inc. Multiple imaging mode tissue marker
US11471244B2 (en) 2006-12-12 2022-10-18 C.R. Bard, Inc. Multiple imaging mode tissue marker
US10682200B2 (en) 2006-12-12 2020-06-16 C. R. Bard, Inc. Multiple imaging mode tissue marker
US9901415B2 (en) 2006-12-12 2018-02-27 C. R. Bard, Inc. Multiple imaging mode tissue marker
US9042965B2 (en) 2006-12-18 2015-05-26 C. R. Bard, Inc. Biopsy marker with in situ-generated imaging properties
US8401622B2 (en) 2006-12-18 2013-03-19 C. R. Bard, Inc. Biopsy marker with in situ-generated imaging properties
US20080234572A1 (en) * 2007-03-23 2008-09-25 Civco Medical Instruments Co., Inc. Fiducial marker with absorbable connecting sleeve and absorbable spacer for imaging localization
US8311610B2 (en) 2008-01-31 2012-11-13 C. R. Bard, Inc. Biopsy tissue marker
US9327061B2 (en) 2008-09-23 2016-05-03 Senorx, Inc. Porous bioabsorbable implant
US11833275B2 (en) 2008-09-23 2023-12-05 Senorx, Inc. Porous bioabsorbable implant
US10786604B2 (en) 2008-09-23 2020-09-29 Senorx, Inc. Porous bioabsorbable implant
US11779431B2 (en) 2008-12-30 2023-10-10 C. R. Bard, Inc. Marker delivery device for tissue marker placement
US10258428B2 (en) 2008-12-30 2019-04-16 C. R. Bard, Inc. Marker delivery device for tissue marker placement
US8670818B2 (en) 2008-12-30 2014-03-11 C. R. Bard, Inc. Marker delivery device for tissue marker placement
US9943704B1 (en) 2009-01-21 2018-04-17 Varian Medical Systems, Inc. Method and system for fiducials contained in removable device for radiation therapy
US9936892B1 (en) * 2009-05-04 2018-04-10 Cortex Manufacturing Inc. Systems and methods for providing a fiducial marker
US10952632B2 (en) 2009-05-04 2021-03-23 Cortex Manufacturing Inc. Imaging fiducial markers and methods
US20210219956A1 (en) * 2013-01-18 2021-07-22 The Johns Hopkins University Ultrasound-detectable markers, ultrasound system, and methods for monitoring vascular flow and patency
US11382714B2 (en) * 2013-01-18 2022-07-12 The Johns Hopkins University Ultrasound-detectable markers, ultrasound system, and methods for monitoring vascular flow and patency
US11490987B2 (en) * 2013-01-18 2022-11-08 The Johns Hopkins University Ultrasound-detectable markers, ultrasound system, and methods for monitoring vascular flow and patency
USD716451S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD716450S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD715942S1 (en) 2013-09-24 2014-10-21 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD715442S1 (en) 2013-09-24 2014-10-14 C. R. Bard, Inc. Tissue marker for intracorporeal site identification

Also Published As

Publication number Publication date
EP3524203A3 (en) 2019-11-27
CA2508982C (en) 2014-08-12
EP3524203A2 (en) 2019-08-14
CA2508982A1 (en) 2005-12-04
EP1602341B1 (en) 2020-01-15
EP1602341A1 (en) 2005-12-07
US8634899B2 (en) 2014-01-21
US20060173280A1 (en) 2006-08-03

Similar Documents

Publication Publication Date Title
US8634899B2 (en) Multi mode imaging marker
JP3315951B2 (en) Incision biopsy device
US10045832B2 (en) Marker or filler forming fluid
US8579931B2 (en) Apparatus for the percutaneous marking of a lesion
US6725083B1 (en) Tissue site markers for in VIVO imaging
Fahey et al. Acoustic radiation force impulse imaging of thermally-and chemically-induced lesions in soft tissues: preliminary ex vivo results
US6758855B2 (en) Target tissue localization device
CA2659484C (en) Tissue site markers for in vivo imaging
US20060079805A1 (en) Site marker visable under multiple modalities
US7074189B1 (en) Endoscopically deliverable ultrasound imaging system and method of use
US20050119562A1 (en) Fibrous marker formed of synthetic polymer strands
WO2001008578A1 (en) Device and method for safe location and marking of a cavity and sentinel lymph nodes
JP2006528907A (en) Fibrous markers and their delivery in the body
CN103648416A (en) System for fiducial deployment
JP2023505114A (en) Marker element for marking tissue
ES2549215T3 (en) Echogenic cuff
AU2005302639A1 (en) Fibrous marker formed of synthetic polymer strands
Santoro et al. Endoanal and endorectal ultrasonographic techniques
Orens et al. Endobronchial ultrasound via the fiberoptic bronchoscope

Legal Events

Date Code Title Description
AS Assignment

Owner name: BARD SHANNON LIMITED, NETHERLANDS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:INRAD, INC.;REEL/FRAME:019628/0205

Effective date: 20070613

Owner name: BARD PERIPHERAL VASCULAR, INC., ARIZONA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:INRAD, INC.;REEL/FRAME:019628/0205

Effective date: 20070613

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: INRAD, INC., MICHIGAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GOOSEN, RYAN L.;FIELD, STEVEN E.;CHESBROUGH, RICHARD M.;SIGNING DATES FROM 20040323 TO 20040416;REEL/FRAME:027156/0536